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Abstract 29 
Programmed –1 ribosomal frameshifting (PRF) in cardioviruses is activated by the 2A protein, 30 
a multi-functional virulence factor that also inhibits cap-dependent translational initiation. Here 31 
we present the X-ray crystal structure of 2A and show that it selectively binds to a pseudoknot-32 
like conformation of the PRF stimulatory RNA element in the viral genome. Using optical 33 
tweezers, we demonstrate that 2A stabilises this RNA element, likely explaining the increase 34 
in PRF efficiency in the presence of 2A. Next, we demonstrate a strong interaction between 35 
2A and the small ribosomal subunit and present a cryo-EM structure of 2A bound to initiated 36 
70S ribosomes. Multiple copies of 2A bind to the 16S rRNA where they may compete for 37 
binding with initiation and elongation factors. Together, these results define the structural basis 38 
for RNA recognition by 2A, show how 2A-mediated stabilisation of an RNA pseudoknot 39 
  
 
2 
 
promotes PRF, and reveal how 2A accumulation may shut down translation during virus 40 
infection. 41 
 42 
Introduction 43 
PRF is a translational control strategy employed by many RNA viruses, where it ensures the 44 
production of proteins in optimal ratios for efficient virus assembly and enables viruses to 45 
expand their coding capacity through the utilisation of overlapping ORFs (reviewed in1-3). In 46 
canonical PRF, elongating ribosomes pause over a heptanucleotide “slippery sequence” of 47 
the form X_XXY_YYZ when they encounter a “stimulatory element” about 5–9 nucleotides 48 
downstream in the mRNA. During this time, a –1 frameshift may occur if codon-anticodon re-49 
pairing takes place over the X_XXY_YYZ sequence: the homopolymeric stretches allow the 50 
tRNA in the P-site to slip from XXY to XXX, and the tRNA in the A-site to slip from YYZ to 51 
YYY4-7. A diverse array of stem-loops and pseudoknots are known to induce frameshifting, 52 
and the stability, plasticity and unfolding kinetics of these RNA elements are thought to be the 53 
primary determinants of PRF efficiency8-10, along with the thermodynamic stability of the 54 
codon-anticodon interactions6. Cardioviruses present a highly unusual variation to 55 
conventional viral PRF in which the virally encoded 2A protein is required as an essential 56 
trans-activator11,12. Here, the spacing between the slippery sequence and stem-loop is 13 nt, 57 
significantly longer than typically seen, and 2A protein has been proposed to bridge this gap 58 
through interaction with the stem-loop12. This allows for temporal control of gene expression 59 
as the efficiency of –1 frameshifting is linked to 2A concentration, which increases with time 60 
throughout the infection cycle12. 61 
 62 
2A is a small, basic protein (~17 kDa; 143 amino acids; pI ~9.1) generated by 3C-mediated 63 
proteolytic cleavage at the N-terminus13 and Stop-Go peptide release at the C-terminus14. 64 
Despite the identical name, it has no homology to any other picornavirus “2A” protein15, nor 65 
any other protein of known structure. The PRF-stimulatory activity of 2A is related to its ability 66 
to bind to the RNA stimulatory element12. However, 2A also binds to 40S ribosomal subunits16, 67 
inhibits apoptosis17 and contributes to host cell shut-off by inhibiting cap-dependent 68 
translation. A C-terminal YxxxxLΦ motif has been proposed to bind to and sequester eIF4E in 69 
a manner analogous to eIF4E binding protein 1 (4E-BP1)16, thereby interfering with eIF4F 70 
assembly18. However, the absence of structural data has precluded a definitive molecular 71 
characterisation of this multi-functional protein, and the mechanism by which it recognises 72 
RNA elements and stimulates frameshifting remains obscure.  73 
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 74 
Here we present the crystal structure of 2A from encephalomyocarditis virus (EMCV), 75 
revealing a novel RNA-binding fold that we term a “beta-shell”. We show that 2A binds directly 76 
to the frameshift-stimulatory element in the viral RNA with nanomolar affinity and equimolar 77 
stoichiometry, and we define the minimal RNA element required for binding. Through site-78 
directed mutagenesis and the use of single-molecule optical tweezers, we study the dynamics 79 
of this RNA element, both alone and in the presence of 2A. By observing short-lived 80 
intermediate states in real-time, we demonstrate that the EMCV stimulatory element exists in 81 
at least two conformations and 2A binding stabilises one of these, an RNA pseudoknot, 82 
increasing the force required to unwind it. Finally, we report a direct interaction of 2A with both 83 
mammalian and bacterial ribosomes. High-resolution cryo-electron microscopy (cryo-EM) 84 
characterisation of 2A in complex with initiated 70S ribosomes reveals a multivalent binding 85 
mechanism and defines the molecular basis for RNA recognition by the 2A protein. It also 86 
reveals a likely mechanism of 2A-associated translational modulation, by competing for 87 
ribosome binding with initiation factors and elongation factors. Together, our work provides a 88 
new structural framework for understanding protein-mediated frameshifting and 2A-mediated 89 
regulation of gene expression. 90 
 91 
Results 92 
Structure of EMCV 2A reveals an RNA-binding fold  93 
Following recombinant expression in E. coli, purified 2A was analysed by SEC-MALS, 94 
revealing a predominantly monodisperse, monomeric sample (Fig. 1a, b; observed mass 95 
18032.8 Da vs calculated mass 17930.34 Da), with a small proportion of dimers (observed 96 
mass 40836.0 Da). We crystallised the protein and determined the structure by multiple-97 
wavelength anomalous dispersion analysis of a selenomethionyl derivative. The asymmetric 98 
unit (ASU) of the P6222 cell contains four copies of 2A related by non-crystallographic 99 
symmetry (NCS), and the structure was refined to 2.6 Å resolution (Supplementary Table 1). 100 
Unexpectedly, the four molecules are arranged as a pair of covalent ‘dimers’ with an 101 
intermolecular disulfide bond forming between surface-exposed cysteine residues (C111). 102 
This arrangement is likely an artefact of crystallisation, which took >30 days, possibly due to 103 
the gradual oxidation of C111 promoting formation of the crystalline lattice. The N-terminal 104 
10–12 residues are disordered in all chains except B, in which they make long-range contacts 105 
with another chain. Similarly, C-terminal residues beyond 137 are absent or poorly ordered in 106 
all chains. 107 
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 108 
2A adopts a compact, globular fold of the form β3αβ3αβ (Fig. 1c). Searches of PDBeFOLD19, 109 
DALI20 and CATHEDRAL21 databases failed to reveal structural homology to any other protein, 110 
so we term this fold a “beta shell”. The most striking feature is a curved, seven-stranded anti-111 
parallel beta sheet (Fig. 1d). The concave face of the beta sheet is supported by tight packing 112 
against the two alpha helices: together, this comprises the hydrophobic core of the fold. In 113 
contrast, the solvent-exposed convex face and surrounding loops are enriched with arginine, 114 
lysine and histidine residues, conferring a strong positive electrostatic surface potential at 115 
physiological pH. Superposition of the four NCS-related chains and an analysis of the atomic 116 
displacement factors reveals regions of flexibility (Fig. 1e, f). In addition to the N- and C- 117 
termini, the β2-loop-β3 region (residues 28–37) exists in multiple conformations that deviate 118 
by up to 5.8 Å in the position of the Cα backbone. Similarly, the arginine-rich loop between β5 119 
and β6 (“arginine loop”, residues 93–100) is mobile, with backbone deviations of up to 4.5 Å.  120 
 121 
Several previous studies have described mutations, truncations or deletions in EMCV 2A that 122 
affect its activity22-24. Many of the truncations would severely disrupt the fold and the results 123 
obtained with these mutants should be interpreted with caution. However, the loop truncation 124 
(2AΔ94-100) and point mutations made by Groppo et al.23 would have only minor effects 125 
(Supplementary Fig. 1). Notably, in 2A, a C-terminal YxxxxLΦ motif predicted to bind eIF4E 126 
is within a beta strand, whereas the equivalent motif in 4E-BP1 is alpha-helical25. As a result, 127 
Y129 is partially buried and distal to both L134 and I135. Overlay of our 2A structure with the 128 
structure of the eIF4E:4E-BP1 complex indicates that without a significant conformational 129 
change, this motif is unlikely to represent the mechanism by which 2A recognises eIF4E 130 
(Supplementary Fig. 1). 131 
 132 
2A binds to a minimal 47 nt pseudoknot in the viral RNA 133 
The RNA sequence that directs PRF in EMCV consists of a G_GUU_UUU slippery sequence 134 
and a stimulatory stem-loop element downstream (Fig. 2a). We have previously demonstrated 135 
that three conserved cytosines in the loop are essential for 2A binding12 (Fig. 2a). To map the 136 
interaction between 2A and the stimulatory element in more detail, we prepared a series of 137 
synthetic RNAs with truncations in the shift site, loop, and 5′ and 3′ extensions on either side 138 
of the stem (EMCV 1–6; Fig. 2b). These were fluorescently labelled at the 5′ end, and their 139 
binding to 2A was analysed by electrophoretic mobility shift assay (EMSA; Fig. 2c) and 140 
microscale thermophoresis (MST; Fig. 2d, Supplementary Table 2).  141 
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 142 
Binding of 2A to EMCV 1 RNA is high affinity (KD = 360 ± 34 nM). Removal of the 3′ extension, 143 
as in EMCV 3 and EMCV 6, further increases the affinity (KD values of 40 ± 2 and 70 ± 14 nM, 144 
respectively), perhaps by removing competing base-pairing interactions. There is no 145 
substantial difference between affinities of EMCV 3 and 6, which differ only by the presence 146 
of the shift site. Removal of the 5′ extension, as in EMCV 2 and EMCV 4, completely abolishes 147 
2A binding, and truncation of the loop, including a putative second stem (EMCV 5) reduces 148 
binding to micromolar levels. Truncating the disordered N- and C- termini of 2A, or mutating 149 
the disulfide-forming C111 residue has no effect on RNA binding (Supplementary Fig. 2). To 150 
investigate stoichiometry, we performed an isothermal titration calorimetry (ITC) analysis of 151 
the interaction between 2A and EMCV 6 (Supplementary Fig. 2). Equimolar binding was 152 
observed, with a measured KD (246 ± 72 nM), similar to those obtained using MST. The 153 
dominance of enthalpy (ΔH, –13.9 ± 0.81 kcal/mol) to the overall free energy of binding (ΔG, 154 
–9.02 kcal/mol) indicates an interaction mechanism driven by hydrogen bond or electrostatic 155 
contact formation. Finally, reciprocal MST experiments with fluorescently labelled 2A and 156 
unlabelled RNA yielded similar KD values (Supplementary Fig. 2, Supplementary Table 2). 157 
 158 
We next asked whether these small RNAs could act as competitors to sequester 2A and 159 
reduce the efficiency of PRF in rabbit reticulocyte lysate (RRL) in vitro translation reactions 160 
programmed with a frameshift reporter mRNA (Supplementary Fig. 2). Indeed, when 161 
unlabelled EMCV 1, 3 and 6 were added in excess, they were able to compete with the 162 
stimulatory element present in the reporter, thereby reducing the amount of the –1 frame 163 
product. In contrast, EMCV 2, 4 and 5 had no such effect, reinforcing the results of direct 164 
binding experiments. 165 
 166 
The failure of 2A to bind to EMCV 2, 4 and 5 was unexpected as these RNAs retain the main 167 
stem and the conserved cytosine triplet in the putative loop region. A possible explanation is 168 
that the frameshift-relevant state may include an interaction between the loop and the 5′ 169 
extension, forming a different conformation that 2A selectively recognises. To test this, we 170 
carried out mutagenesis of the 5′ extension and loop C-triplet. Individually, G7C and C37G 171 
mutations both reduce 2A-dependent PRF to near-background levels (Supplementary Fig. 172 
3). However, in combination, the G7C+C37G double mutation restores PRF to wild-type 173 
levels, and EMSA experiments with these mutants confirm that this is due to inhibition and 174 
restoration of 2A binding. Together, this demonstrates the likelihood of a base-pair between 175 
positions 7 and 37 that is necessary to form a conformation that 2A selectively recognises. 176 
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Using this base pair as a restraint, RNA structure prediction26,27 reveals a pseudoknot-like fold 177 
(Supplementary Fig. 3). 178 
 179 
Single-molecule measurements of stimulatory element unwinding reveal several 180 
conformations 181 
Information is limited in ensemble measurements of RNA-protein interactions due to molecular 182 
averaging. To further explore the effects of 2A on unfolding and refolding of individual EMCV 183 
RNA molecules, we used optical tweezers (Fig. 3a). In force-ramp experiments, a single RNA 184 
molecule is gradually stretched and relaxed in several cycles at a constant pulling rate. The 185 
applied force allows the RNA molecule to transition between folded and unfolded states, and 186 
sudden changes in recorded force-distance trajectories indicate transitions between RNA 187 
conformations (Fig. 3c, d)28-30. By mathematically fitting each force-distance curve (Methods) 188 
we can obtain information on the physical properties of the RNA such as the change in the 189 
contour length (maximum possible extension), which indicates whether our data are physically 190 
consistent with predicted structures of the EMCV RNA. In addition to the pseudoknot (40 nt, 191 
discussed above), mfold31 suggested two other possible conformations for the frameshift 192 
stimulatory element: a stem loop (35 nt) and an extended stem-loop with additional 193 
interactions between 5’ and 3’ flanking regions (49 nt) (Fig. 3b, Supplementary Table 6). 194 
Alongside the wild-type EMCV RNA sequence (WT), we also used a mutant with a substitution 195 
in the cytosine triplet (CUC) which is known be crucial for 2A binding and PRF12 (Fig. 3a; 196 
lower). 197 
 198 
We initially monitored the unfolding and refolding of WT and CUC RNAs in the absence of 2A. 199 
In WT RNA, the majority of force-distance (FD) trajectories were characterized by a single rip 200 
at 9.3 ± 2.3 pN force (Fig. 3c, e). Upon release of the force, the molecules readily refolded at 201 
6.5 ± 3.0 pN, showing that the process is reversible (Fig. 3c, f, Supplementary Table 3). The 202 
change in contour length calculated from the fits was approximately 26.3 ± 5.4 nm 203 
(Supplementary Fig. 4, Supplementary Table 3) corresponding to a length of 46 single-204 
stranded nucleotides. This is in close agreement with the predicted 49 nt long extended stem-205 
loop formed by the EMCV PRF RNA (Fig. 3b, Supplementary Table 6). Interestingly, we 206 
observed similar (un)folding trajectories with the CUC RNA, with a rip occurring at 8.6 ± 4.2 207 
pN and a contour length change of about 27.2 ± 4.3 nm (Fig. 3e, f, Supplementary Fig. 4, 208 
Supplementary Table 3), suggesting both RNAs would essentially fold into a stem-loop of 209 
similar length.  210 
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 211 
In a small fraction of WT FD trajectories (~12 %) we observed a single unfolding event at 212 
higher forces above 20 pN, while refolding was unchanged (6.5 ± 3.0 pN), suggesting the 213 
existence of a WT conformer with resistance to unfolding. Indeed, the putative EMCV 214 
pseudoknot would comprise 40 nucleotides, and lead to an expected difference of 23 nm in 215 
contour length upon unfolding (Supplementary Fig. 4, Supplementary Table 6). Since both 216 
the predicted pseudoknot and extended-stem loop are of similar length, and the distributions 217 
of contour length change are quite broad, this parameter is not precise enough to 218 
unambiguously distinguish between these conformations. On the other hand, the resistance 219 
to unfolding and hysteresis during refolding are well-known characteristics of more complex 220 
structures such as pseudoknots9,32, and this is also consistent with our mutational analysis 221 
(Supplementary Fig. 3; discussed above). Furthermore, these higher force unfolding events 222 
are not observed in the CUC mutant, which is very unlikely to form a pseudoknot 223 
(Supplementary Fig. 4, Supplementary Table 3).     224 
 225 
Next, we compared the energetics of folding and unfolding of the conformers. In optical 226 
tweezer experiments, the work of unfolding is the work required to extend the folded RNA 227 
construct (dsDNA:RNA handles and dsRNA) minus the work required to extend the fully 228 
unfolded (dsDNA:RNA handles and ssRNA) construct (W=Wds−Wds+ss). Accordingly, free 229 
energy values of WT and CUC constructs were calculated as −13.6 ± 4.6 and −14.5 ± 4.7 230 
kcal/mol, respectively, which are close to the mfold-predicted Gibbs free energy values for the 231 
stem loop (−14 ± 0.7 kcal/mol) and extended stem-loop (−16.2 ± 0.8 kcal/mol) 232 
(Supplementary Table 3). This further supports the view that the EMCV WT and CUC mutant 233 
RNAs predominantly fold into the predicted stem-loops. 234 
 235 
2A favours the formation of an alternative conformation with resistance to mechanical 236 
unwinding 237 
We next tested how 2A binding influences RNA stability and resistance of RNA to mechanical 238 
unwinding. For the wild-type RNA, global analysis of the unfolding forces reveals a 2A-induced 239 
stabilisation, which increased the fraction of unfolding events at higher forces (27.0 ± 4.2 pN) 240 
(Fig. 3d, e, Supplementary Fig. 4, Supplementary Table 3). However, refolding of the RNA 241 
was mostly unaffected (Fig. 3d, f, Supplementary Table 3). Probability distributions of the 242 
change in contour length show a peak at around 20.0 ± 3.4 nm (Supplementary Fig. 4, 243 
Supplementary Table 3) which may reflect the unfolding of either the stem-loop (21 nm 244 
  
 
8 
 
expected) or the proposed pseudoknot conformation (23 nm expected) (Fig. 3b, 245 
Supplementary Fig. 4, Supplementary Table 6).   246 
 247 
Subsequently, we examined 2A binding to the CUC mutant RNA (Supplementary Fig. 4). In 248 
contrast to the wild type RNA, within this population we did not observe any stabilisation in the 249 
presence of 2A (Fig. 3e, Supplementary Fig. 4). Thus, the unfolding and refolding force 250 
distributions overlap with those observed for CUC RNA in absence of 2A (Fig. 3e, f, 251 
Supplementary Fig. 4, Supplementary Table 3). We observed a small shift in the distribution 252 
of contour length changes towards lower values, which could be either due to non-specific 253 
interactions or stochastic noise. Overall, the lack of effect of 2A on the CUC RNA agreed well 254 
with the ensemble analysis of 2A:RNA interactions.  255 
 256 
To further dissect the effect of 2A on EMCV RNAs, we calculated the work performed on the 257 
WT and CUC RNAs during (un)folding in the presence of 2A (Supplementary Fig. 4). For 258 
CUC RNA with 2A, the unfolding and refolding work distributions were largely overlapping, so 259 
the process can be considered reversible. We obtained a free energy value of −15.5 ± 5.0 260 
kcal/mol, which is within the range of mfold predicted free energy values for the CUC stem-261 
loop (−14 ± 0.7 kcal/mol) and the extended stem-loop (–16.2 ± 0.8 kcal/mol). For WT RNA 262 
with 2A, the stabilisation effect shifted the calculated free energy to −26.5 ± 8.7 kcal/mol, thus 263 
moving the system away from equilibrium (Supplementary Table 3)33,34. The 2A-induced 264 
decrease in free energy of the wild-type RNA may be a combination of stabilisation induced 265 
by protein binding, and a change in RNA conformation. Taken together, our results support 266 
that 2A binding stabilises the EMCV stimulatory RNA element and increases its resistance to 267 
mechanical unwinding.   268 
 269 
2A interacts with the small ribosomal subunit in both eukaryotes and prokaryotes 270 
In addition to its role as a component of the stimulatory element, 2A has been reported to bind 271 
to 40S subunits in EMCV-infected cells16. To determine if the interaction of 2A with the 40S 272 
subunit can be reproduced ex vivo, we purified ribosomal subunits from native RRL and 273 
analysed 2A-subunit interactions by MST (Fig. 4a, b). Consistent with previous data, 2A forms 274 
a tight complex with 40S (apparent KD = 10 ± 2 nM) but not 60S. This apparent selectivity for 275 
the small subunit was also observed with purified prokaryotic ribosome subunits. 2A binds with 276 
very high affinity to 30S (apparent KD = 4 ± 1 nM; Fig. 4c), but not 50S (Fig. 4d). We next 277 
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examined binding of 2A to intact 70S ribosomes and to reconstituted, mRNA-bound 70S 278 
ribosomes at the initiation stage (70S IC; initiator tRNAMet in the P-site and an empty A-site). 279 
We were able to detect high affinity interactions with both uninitiated and initiated 70S 280 
ribosomes (Fig. 4e, f).  281 
 282 
Prokaryotic ribosomes are responsive to 2A-mediated frameshifting  283 
Prokaryotic translation systems are well-established models for studying eukaryotic PRF 284 
signals35,36 but it is unknown whether they can support protein-dependent PRF. To address 285 
this, we measured the efficiency of the EMCV signal in a reconstituted prokaryotic translation 286 
system and in E. coli S30 extracts using frameshift reporter mRNAs (Supplementary Fig. 5). 287 
In each case, 2A-dependent PRF was observed, with ~7% of ribosomes changing frame. 288 
Mutagenesis of either the shift site or the CCC triplet disabled PRF. Shortening the length of 289 
the spacer to one more optimal for prokaryotic ribosomes (from 13 to 12 nt) doubled PRF 290 
efficiency to ~15%, comparable to that measured in eukaryotic in vitro translation systems 291 
(20%)12. High concentrations of 2A also had an inhibitory effect on translation, similar to that 292 
seen in eukaryotic systems. 293 
 294 
Cryo-EM structure of a 2A-ribosome complex reveals the structural basis for RNA recognition 295 
and translational pathology  296 
Having validated the use of prokaryotic ribosomes as a model system to study protein-297 
dependent PRF, we prepared complexes between 2A and the initiated 70S ribosomes and 298 
imaged them by cryo-EM (Fig. 5a, Supplementary Table 4). After processing 299 
(Supplementary Fig. 6), the final 3D reconstruction produced a density map of 2.7 Å 300 
resolution and revealed three copies of 2A bound directly to 16S rRNA of the 30S subunit in 301 
a tripartite cluster (Fig. 5b, c). The local resolution for 2A was sufficient to allow sidechain 302 
modelling and refinement. All three 2A molecules use the same RNA-binding surface 303 
(comprising variations of R46, K48, K50, K73, K94, R95 and R97) (Fig. 5d), to recognise the 304 
ribose phosphate backbone through numerous polar and electrostatic contacts (Fig. 6a–c). 305 
We mutated this putative interaction surface (Supplementary Fig. 5) and observed reduced 306 
binding to both the stimulatory element RNA and mammalian ribosome subunits and a 307 
decreased activity in stimulating PRF in vitro. 2AR95A/R97A was completely functionally defective, 308 
whilst 2AK73A and 2AR46A/K48A/K50A exhibited moderate and mild effects, respectively. 309 
 310 
  
 
10 
 
By comparing the quality of both the overall density for each 2A molecule, and the side-chain 311 
density at the interaction surface, we can rank the three binding sites 2A1 > 2A2 > 2A3 in 312 
order of likely affinity. 2A1 is the most well-ordered molecule, and the 2A1 binding site on the 313 
rRNA is also the most conserved between prokaryotic and mammalian ribosomes 314 
(Supplementary Fig. 7) This is therefore likely the most physiologically relevant site, and it is 315 
possible that 2A2 and 2A3 represent lower-affinity sites (a ~40-fold molar excess of 2A was 316 
used to prepare grids). 2A1 exemplifies the critical role of the “arginine loop” (Fig. 6d). R95, 317 
R97 and R100 side chains are inserted into a ~90° junction between helices 3 and 4, forming 318 
a network of electrostatic interactions that bridge the phosphate groups on both strands. This 319 
is further stabilised by the guanidinium groups stacking against each other and exposed bases 320 
(G38) (Fig. 6d). Arginine loop residues also form polar and electrostatic contacts at the 2A2 321 
and 2A3 interfaces (Fig. 6e, f). Whilst base-specific contacts are rare, 2A2 interacts with U485 322 
which is normally flipped out of helix 17 (Supplementary Fig. 8). Superposition of the rRNA 323 
binding sites failed to reveal a common structural motif for RNA recognition (Supplementary 324 
Fig. 7), thus conformational plasticity of side chains at the RNA-binding surface (Fig. 5d) 325 
explains how this protein can recognise a several RNA targets. There are also intermolecular 326 
contacts between 2A protomers, consistent with our observations of multimers by SEC-MALS 327 
(Fig. 1b) and EMSA (Fig. 2c). In a subset of the data, a fourth copy of 2A (2A4) was identified 328 
to bind helix 33 of the 16S rRNA ‘beak’ in the 30S head. Although local resolution was only 329 
sufficient for docking, 2A4 uses the same RNA-binding surface to recognise the distorted 330 
helical backbone (Supplementary Fig. 8). 331 
 332 
The ribosome is in an unrotated state that would normally be elongation competent, with fMet-333 
tRNAi base-paired to the initiator codon in the P-site and mRNA available for amino-acyl tRNA 334 
delivery to the A-site37 (Fig. 7a). There are no 2A-induced rearrangements at the decoding 335 
centre (Supplementary Fig. 8) but the presence of 2A on the 30S subunit occludes the 336 
binding site for translational GTPases. 2A1 occupies a position that would severely clash with 337 
domain II of EF-G in both compact and extended pre- and post-translocation states38,39 (Fig. 338 
7b). It also makes direct hydrophobic contacts with the face of S12 that would normally interact 339 
with domain III of EF-G. This 2A interaction surface on S12 is directly adjacent to the binding 340 
site for antibiotic dityromycin, which inhibits translocation by steric incompatibility with the 341 
elongated form of EF-G40 (Supplementary Fig. 8). 2A1 would also clash significantly with 342 
domain II of EF-Tu during delivery of aminoacyl tRNAs to the A-site41,42 (Fig. 7c). In a similar 343 
way, 2A2 would be detrimental to both EF-G and EF-Tu binding (Fig. 7b, c). We therefore 344 
predict that 2A binding would be inhibitory to elongation and potentially initiation, via 345 
competition with IF2 during pre-initiation complex assembly43.  346 
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 347 
Discussion 348 
Here we show that 2A adopts an RNA-binding fold, allowing specific recognition and 349 
stabilisation of the PRF stimulatory element in the viral RNA and direct binding to host 350 
ribosomes. Given this structural framework, we can reinterpret several preceding biochemical 351 
and virological observations. Many functions of 2A can be assigned to a single positively 352 
charged surface loop (“arginine loop” residues 93–100). Despite the low pairwise sequence 353 
identity of 2A proteins amongst Cardioviruses, R95 and R97 are completely conserved. This 354 
region was originally described as a nuclear localisation sequence (NLS)23 and subsequently, 355 
we demonstrated that these residues are essential for PRF activity in both EMCV and Theiler’s 356 
murine encephalomyelitis virus (TMEV), and that their mutation to alanine prevents 2A binding 357 
to the stimulatory element in the viral RNA12,44 (Supplementary Fig. 5). Here we reveal how 358 
R95 and R97 also mediate direct 2A binding to the small ribosomal subunit (Fig. 6d–f) and 359 
therefore also likely confer other 2A-associated translational activities. Importantly, 2A uses 360 
the same molecular surface to bind to both the PRF stimulatory element and to ribosomes 361 
(Fig. 6d–f, Supplementary Fig. 5), so for any given 2A molecule these events are mutually 362 
exclusive. This suggests that the primary determinant of −1 PRF is likely to be 2A binding to 363 
the stimulatory element, with ribosome binding having a secondary effect. If 2A were to act as 364 
a “bridge” between the stimulatory element and the ribosome, this would necessitate two 365 
separate interactions surfaces, which we do not observe.  366 
 367 
Our cryo-EM structure unexpectedly revealed four distinct 2A:rRNA interfaces (Fig. 6 and 368 
Supplementary Fig. 8). Based on the quality of cryo-EM density and the degree of structural 369 
conservation between prokaryotic and mammalian ribosomes, the 2A1 site is likely to be the 370 
highest affinity and most physiologically relevant (Supplementary Fig. 7). Nevertheless, all 371 
sites provide clues as to how RNA-binding specificity is achieved. RNA recognition is driven 372 
almost exclusively by electrostatic interactions between arginine or lysine side chains and the 373 
ribose phosphate backbone oxygen atoms. The mobility and flexibility of the arginine loop and 374 
other residues at the RNA binding surface (Fig. 1f, 5d) illustrates how 2A can recognise a 375 
variety of structurally degenerate targets. Whilst superposition of sites failed to reveal a 376 
common structural motif (Supplementary Fig. 7), they all include features such as kinks, 377 
distortions and junctions between multiple helices. A preference for these features is 378 
consistent with our biochemical observations that 2A is unable to bind EMCV 2, 4 and 5 RNAs, 379 
which are predicted to form stable, undistorted stem-loops (Fig. 2c, d). There is a strong 380 
likelihood that, in the 2A-bound state, the conformation of the EMCV RNA that stimulates PRF 381 
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involves additional base-pairs between C-residues in the loop and a GG pair in the 5′ extension 382 
(Supplementary Fig. 3). This pseudoknot-like conformation may either pre-exist in 383 
equilibrium with other states, or it may be directly induced by 2A binding (Fig. 8). Whilst we 384 
have been unable to capture a snapshot of this molecular recognition event, it likely comprises 385 
the structural basis for the molecular “switch” that activates frameshifting during EMCV 386 
infection.  387 
 388 
Our single-molecule data now also provide a physical explanation for this molecular “switch”. 389 
It was previously shown that ribosome can exert forces of up to 20 pN during elongation45. We 390 
show that, in the absence of 2A, both WT and CUC RNAs unfold at forces around ~10 pN, 391 
well within the ribosome-achievable force range and hence unlikely to cause a ribosomal 392 
pause. However, in the presence of 2A, WT but not CUC RNAs are stabilised to unwind at 393 
~27 pN, presenting a considerable blockade to ribosome progression (Fig. 3d). This also 394 
supports the idea that the failure of the CUC mutant to stimulate PRF is due to its inability to 395 
adopt the pseudoknot-like conformation of the “switch” that would normally be selectively 396 
recognised and stabilised by 2A.  397 
 398 
Our current mechanistic understanding of PRF is largely informed by ensemble kinetic and 399 
single-molecule FRET studies of prokaryotic ribosomes4-6,46-48. Frameshifting occurs late 400 
during the EF-G mediated translocation step, in which the stimulatory element traps ribosomes 401 
in a rotated or hyper-rotated state, accompanied by multiple abortive EF-G binding attempts 402 
and rounds of GTP hydrolysis. Stability of the RNA stimulatory element structure downstream 403 
of the slippery sequence is thought to be an important determinant of the frameshifting 404 
efficiency9,49,50 although the plasticity of this structure, and the ability to adopt alternate 405 
conformations, is also a key property10. Several recent studies emphasise the importance of 406 
the energetics of codon:anticodon base-pairing at the slippery sequence6,51, suggesting that 407 
the primary role of the stimulatory element is to simply pause the ribosome over a permissive 408 
slippery sequence in which the tRNA-mRNA base pairing energies in the 0 and −1 frames are 409 
similar. Longer pauses at a more stable stimulatory element allow an equilibrium to be 410 
established between the 0 and −1 frames, converging on a maximum frameshift efficiency of 411 
~50%. We have demonstrated how 2A-mediated stabilisation of the stimulatory element likely 412 
presents a potent elongation blockade allowing this equilibrium to be established (Fig. 3e, 8). 413 
However, this mechanism alone cannot explain the very high PRF efficiencies (up to ~70%) 414 
observed by ribosome profiling during EMCV infection12,44.  415 
 416 
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Based on our structure, it is tempting to speculate that competition between EF-G/eEF2 and 417 
2A1 binding might have a role in prolonging the pause, thereby contributing to the high PRF 418 
efficiencies that we observe in 2A-dependent systems52. Indeed, direct interactions between 419 
the ribosome and PRF stimulatory elements are not unprecedented, with a recent study 420 
describing how the HIV-1 stem-loop induces a pause by binding to the 70S A-site and 421 
preventing tRNA delivery48. The ribosome-bound form of 2A that we observe could therefore 422 
be a secondary ‘enhancer’ of PRF efficiency, acting synergistically with the main stimulatory 423 
element. It could also be relevant to the resolution of the elongation blockade: by providing an 424 
alternative 2A-binding surface that competes with the viral RNA, the ribosome may help to 425 
induce 2A dissociation from the stimulatory element during a pause at the PRF site. 426 
Alternatively, it may not be directly relevant to frameshifting per se, instead representing a way 427 
of interfering with host cell translation as 2A accumulates during infection.  428 
 429 
In conclusion, this work defines the structural and molecular basis for the temporally regulated 430 
‘switch’ behind the reprogramming of viral gene expression in EMCV infection (Fig. 8). At the 431 
heart of this is 2A: an RNA-binding protein with the remarkable ability to discriminate between 432 
stem-loop and pseudoknot conformers of the PRF stimulatory element. We also reveal how 433 
2A interferes with host translation by specifically recognising distinct conformations within the 434 
ribosomal RNA. Together, this illustrates how the conformational plasticity of one RNA-binding 435 
surface can contribute to multiple functions through finely tuned relative affinities for different 436 
cellular targets.  437 
 438 
Methods 439 
Materials availability 440 
Further information and requests for resources should be directed to and will be fulfilled by 441 
Ian Brierley (ib103@cam.ac.uk). Plasmids generated in this study are available on request. 442 
DNA and RNA oligonucleotides are standard synthetic products that are commercially 443 
available (see Supplementary Table 5).  444 
 445 
Cloning, protein expression and purification 446 
All gene cloning, manipulation and plasmid propagation steps involving pGEX6P1 or pOPT 447 
vectors were carried out in Escherichia coli DH5α cells grown at 37 °C in 2 × TY or LB media 448 
supplemented with appropriate selection antibiotics. EMCV 2A cDNA was amplified by PCR 449 
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from previously described plasmid 2A_pGEX6P112 (primers E2A_F1 and E2A_R1; 450 
Supplementary Table 5) and cloned into pOPTnH53 using NdeI and BamHI sites, thereby 451 
introducing a C-terminal GlySerLysHis6 tag. The 2A9-136 truncated construct was cloned in an 452 
identical way (primers E2A_F2 and E2A_R2; Supplementary Table 5). The EMCV 2A 453 
R95A/R97A mutant was cloned into pOPTnH after PCR-amplification from a previously 454 
described 2A_pGEX6P1 construct containing these mutations12. Other EMCV 2A mutants 455 
were prepared by PCR mutagenesis, using either the wild-type EMCV 2A_pOPT or 2A9-456 
136_pOPT plasmids as templates, with the following primer pairs (C111S: E2A_mut_F1 and 457 
E2A_mut_R1; R46A/K48A/K50A: E2A_mut_F2 and E2A_mut_R2; K74A: E2A_mut_F3 and 458 
E2A_mut_R3; Supplementary Table 5). To introduce an N-terminal StrepII-tag (SII-2A), 459 
annealed oligonucleotides encoding the StrepII-tag (SII_F and SII_R, Supplementary Table 460 
5) were inserted in-frame at the BamHI site of 2A_pGEX6P1.  461 
 462 
Recombinant proteins 2A, 2A9-136; C111S, 2AR95A/R97A, 2AR46A/K48A/K50A and 2AK73A were expressed 463 
in E. coli BL21 (DE3) pLysS cells grown in 2 × TY broth supplemented with 100 μg/mL 464 
ampicillin and 12.5 μg/mL chloramphenicol (37 °C, 200 rpm) until an OD600nm of 0.6 – 1.0 was 465 
reached. Expression was induced with 0.5 mM IPTG for either 4 h at 37 °C or overnight at 21 466 
°C. For selenomethionyl derivatisation (2ASeMet), protein was expressed in E. coli B834 cells, 467 
grown shaking (210 rpm, 37°C) in SeMet base media (Molecular Dimensions) supplemented 468 
with nutrient mix, 40 μg/mL L-selenomethionine and 100 μg/mL ampicillin. Expression was 469 
induced as above.  470 
 471 
Cells were harvested by centrifugation (4,000 × g, 4°C, 20 min), washed once in ice-cold PBS 472 
and stored at -20°C. Pellets from four litres of culture were resuspended in cold lysis buffer 473 
(50 mM Tris-HCl pH 8.0, 500 mM NaCl, 30 mM imidazole, supplemented with 50 μg/mL DNase 474 
I and EDTA-free protease inhibitors) and lysed by passage through a cell disruptor at 24 kPSI 475 
(Constant Systems). Lysate was cleared by centrifugation (39,000 × g, 40 min, 4°C) prior to 476 
incubation (1 h, 4°C) with 4.0 mL of Ni-NTA agarose (Qiagen) pre-equilibrated in the same 477 
buffer. Beads were washed in batch four times with 200 mL buffer (as above, but without 478 
DNase or protease inhibitors) by centrifugation (600 × g, 10 min, 4°C) and re-suspension. 479 
Washed beads were pooled to a gravity column prior to elution over 10 column volumes (CV) 480 
with 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 300 mM imidazole. Fractions containing 2A were 481 
pooled and dialysed (3K molecular weight cut-off (MWCO), 4°C, 16 h) against 1 L buffer A (50 482 
mM Tris-HCl pH 8.0, 400 mM NaCl, 5.0 mM DTT) before heparin-affinity chromatography to 483 
remove contaminating nucleic acids. Samples were loaded on a 10 mL HiTrap Heparin column 484 
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(GE Healthcare) at 2.0 mL/min, washed with two CV of buffer A and eluted with a 40%  485 
100% gradient of buffer B (50 mM Tris-HCl pH 8.0, 1.0 M NaCl, 5.0 mM DTT) over 10 CV. 486 
Fractions containing 2A were pooled and concentrated using an Amicon® Ultra centrifugal 487 
filter unit (10K MWCO, 4,000 × g). Size exclusion chromatography was performed using a 488 
Superdex 75 16/600 column pre-equilibrated in 10 mM HEPES pH 7.9, 1.0 M NaCl, 5.0 mM 489 
DTT. Purity was judged by 4-20% gradient SDS-PAGE, and protein identity verified by mass 490 
spectrometry. Purified protein was used immediately or was concentrated as above (~ 7.0 491 
mg/mL, 390 μM), snap-frozen in liquid nitrogen and stored at -80°C. Variants of 2A, including 492 
2A9-136;C111S and 2ASeMet were purified identically to the wild-type protein. The StrepII-tagged 493 
variant (SII-2A) was expressed and purified using GST-affinity as previously described12. 494 
Following removal of the GST tag by 3C protease, SII-2A was further purified by Heparin affinity 495 
and size-exclusion chromatography as above.   496 
 497 
Size-exclusion chromatography coupled to multi-angle light scattering (SEC-MALS)  498 
Per experiment, 100 μL of protein was injected onto a Superdex 75 increase 10/300 GL 499 
column (GE Healthcare) pre-equilibrated with 20 mM Tris-HCl, 1.0 M NaCl (0.4 mL/min flow, 500 
25°C). Experiments were performed with 5.2 mg/mL 2A (corresponding to a molar 501 
concentration of 290 μM). The static light scattering, differential refractive index, and the UV 502 
absorbance at 280 nm were measured in-line by DAWN 8+ (Wyatt Technology), Optilab T-503 
rEX (Wyatt Technology), and Agilent 1260 UV (Agilent Technologies) detectors. The 504 
corresponding molar mass from each elution peak was calculated using ASTRA 6.1 software 505 
(Wyatt Technology).  506 
 507 
Protein crystallization 508 
Purified EMCV 2A was concentrated to 5.9 mg/ml in 10 mM HEPES pH 7.9, 1.0 M NaCl, 2.0 509 
mM DTT. Diffraction-quality native 2A crystals were grown at 21°C by sitting-drop vapor 510 
diffusion against an 80 μL reservoir of 0.625 M (NH4)2SO4, 0.15 M tri-sodium citrate pH 5.7. 511 
Notably, crystal growth was only visible after 30 days. Drops were prepared by mixing 200 nL 512 
protein and 200 nL crystallization buffer. Selenomethionyl derivative 2A (2ASeMet) was 513 
concentrated to 5.7 mg/mL in 10 mM HEPES pH 7.9, 1.0 M NaCl, 2.0 mM DTT, and diffraction-514 
quality 2ASeMet crystals were grown as above against an 80 μL reservoir of 0.675 M (NH4)2SO4, 515 
0.15 M tri-sodium citrate pH 5.7. Crystals were cryo-protected by the addition of 0.5 μL 516 
crystallization buffer supplemented with 20% v/v glycerol, prior to harvesting in nylon loops 517 
and flash-cooling by plunging into liquid nitrogen. 518 
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 519 
X-ray data collection, structure determination, refinement and analysis 520 
Native datasets (Supplementary Table 1) of 900 images were recorded at Diamond Light 521 
Source, beamline I03 (λ = 0.9796 Å) on a Pilatus 6M detector (Dectris), using 100% 522 
transmission, an oscillation range of 0.2° and an exposure time of 0.04 s per image. Data were 523 
collected at a temperature of 100 K. Data were processed with the XIA254 automated pipeline, 524 
using XDS55 for indexing and integration, and AIMLESS56 for scaling and merging. 525 
Crystallographic calculations were performed using the default software parameters unless 526 
otherwise stated. Processing and refinement statistics are detailed in Supplementary Table 527 
1. Resolution cut-off was decided by a CC1/2 value ≥ 0.5 and an I/σ(I) ≥ 1.0 in the highest 528 
resolution shell57. For multiple-wavelength anomalous dispersion (MAD) phasing experiments, 529 
selenomethionyl derivative datasets were ecorded at beamline I03 (peak λ = 0.9796 Å, 530 
12656.0 eV; hrem λ = 0.9763, 12699.4 eV; inflexion λ = 0.9797 Å, 12655.0 eV). Data were 531 
processed as above using XIA2, XDS and AIMLESS. The structure was solved by three-532 
wavelength anomalous dispersion analysis of the selenium derivative (space group P6222) 533 
performed using the autoSHARP pipeline58, implementing SHELXD59 for substructure 534 
determination, SHARP for heavy-atom refinement and phasing, SOLOMON60 for density 535 
modification and ARP/wARP61 for automated model building. This was successful in placing 536 
503/573 (87%) residues in the asymmetric unit, which comprised four copies of the protein 537 
related by non-crystallographic symmetry (NCS). This initial model was then used to solve the 538 
native dataset by molecular replacement with Phaser 62. The model was completed manually 539 
by iterative cycles of model-building using COOT 0.9.2 63 and refinement with phenix.refine64 540 
(Phenix build 1.18.1_3865), using local NCS restraints and one TLS group per chain. Upon 541 
completion of model building, ISOLDE 1.1 (Croll, 2018) was used to improve model geometry 542 
and resolve clashes prior to a final round of refinement using phenix.refine. MolProbity65 was 543 
used throughout the process to evaluate model geometry. For the electrostatic potential 544 
calculations, partial charges were first assigned using PDB2PQR66, implementing PROPKA 545 
to estimate protein pKa values. Electrostatic surfaces were then calculated using APBS67. 546 
Prior to designation of the “beta shell” as a new fold, structure-based database searches for 547 
proteins with similar folds to EMCV 2A were performed using PDBeFOLD19, DALI20 and 548 
CATHEDRAL21. Buried surface areas were calculated using PDBePISA 68. 549 
 550 
RNA folding prediction  551 
The simRNAweb server26 was used for stem-loop and pseudoknot tertiary structure modelling 552 
of the EMCV stimulatory element. Experimentally-determined base-pairs were input as 553 
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secondary structure restraints. Replica exchange Monte Carlo (REMC) simulated-annealing 554 
was performed with 10 replicas and 16000000 iterations per cycle. Trajectory files from eight 555 
independent simulations were concatenated and clustered, and all-atom PDB files was 556 
generated from the lowest energy state in each of the five most populous clusters. The 3D 557 
models presented (Supplementary Fig. 3) represent the top cluster for pseudoknots and the 558 
top three clusters for stem-loops.     559 
 560 
Electrophoretic Mobility Shift Assay (EMSA) 561 
Synthetic RNA oligonucleotides (Supplementary Table 5, IDT) were dissolved in distilled 562 
water. RNAs were labelled at the 5′ end with A647-maleimide or Cy5-maleimide conjugates 563 
(GE Healthcare) using the 5′ EndTag kit (Vector Labs) as directed by the manufacturer. For 564 
each binding experiment, a series of reactions were prepared on ice, each containing 1.0 μL 565 
500 nM RNA, 1.0 μL serially diluted protein at concentrations of 320, 160, 80, 40, 20, 10, 5.0, 566 
and 2.5 μM in 10 mM HEPES pH 7.9, 1.0 M NaCl, 5.0 μL 2 × buffer (20 mM Tris-HCl pH 7.4, 567 
80 mM NaCl, 4.0 mM magnesium acetate 2.0 mM DTT, 10% v/v glycerol, 0.02% w/v 568 
bromophenol blue, 200 μg/mL porcine liver tRNA, 800 U /mL SUPERase-In [Invitrogen]) and 569 
3.0 μL distilled water. This gave final binding reactions of 10 μL with 50 nM RNA, 1 × buffer, a 570 
salt concentration of ~ 140 mM and proteins at concentrations of 32, 16, 8.0, 4.0, 2.0, 1.0, 0.5 571 
and 0.25 μM. Samples were incubated at 37°C for 20 min prior to analysis by native 10% 572 
acrylamide/TBE PAGE (25 min, 200 V constant). Gels were scanned with a Typhoon FLA-573 
7000 (GE) using the 635 nm laser / R670 filter. Raw, uncropped image data is available in the 574 
Source Data file. 575 
 576 
Isothermal Titration Calorimetry (ITC) 577 
ITC experiments were performed at 25°C using an automated MicroCal PEAQ-ITC platform 578 
(Malvern Panalytical). Proteins and synthetic RNA oligonucleotides (IDT) were dialysed 579 
extensively (24 h, 4°C) into buffer (50 mM Tris-HCl pH 7.4, 400 mM NaCl) prior to experiments. 580 
RNA (52 μM) was titrated into protein (5 μM) with 1 x 0.4 µL injection followed by 12 × 3.0 μL 581 
injections. Control titrations of RNA into buffer, buffer into protein and buffer into buffer were 582 
also performed. Data were analysed using the MicroCal PEAQ-ITC analysis software 1.30 583 
(Malvern Panalytical) and fitted using a one-site binding model. Presented traces were 584 
representative of two independent titrations. 585 
 586 
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Microscale Thermophoresis (MST) 587 
For RNA-binding experiments, synthetic EMCV RNA variants (Supplementary Table 5) were 588 
dissolved in distilled water and labelled at the 5’ end with Dylight 650 maleimide conjugates 589 
(Thermo Scientific) using the 5′ EndTag kit (Vector Labs) as directed by the manufacturer. For 590 
each binding experiment, RNA was diluted to 10 nM in MST buffer (50 mM Tris-HCl pH 7.8, 591 
150 mM NaCl, 10 mM MgCl2, 2 mM DTT supplemented with 0.05% Tween 20) and a series 592 
of 16 tubes with 2A dilutions were prepared on ice in MST buffer, producing 2A ligand 593 
concentrations ranging from 0.00015 to 5 μM for EMCV RNA 2-6 and 0.00006 to 20 μM for 594 
EMCV RNA1. For the measurement, each ligand dilution was mixed with one volume of 595 
labelled RNA, which led to a final concentration of 5.0 nM labelled RNA. The reaction was 596 
mixed by pipetting, incubated for 10 min followed by centrifugation at 10,000 × g for 10 min. 597 
Capillary forces were used to load the samples into Monolith NT.115 Premium Capillaries 598 
(NanoTemper Technologies). Measurements were performed using a Monolith NT.115Pico 599 
instrument (NanoTemper Technologies) at an ambient temperature of 25°C. Instrument 600 
parameters were adjusted to 5% LED power, medium MST power and MST on-time of 10 601 
seconds. An initial fluorescence scan was performed across the capillaries to determine the 602 
sample quality and afterwards 16 subsequent thermophoresis measurements were 603 
performed. To determine binding affinities, data of at least two independently pipetted 604 
measurements were analysed for the fraction bound (MO.Affinity Analysis software, 605 
NanoTemper Technologies). For the non-binders, since the maximum amplitude would 606 
numerically be zero, deltaFnorm values were divided by the average maximum amplitude of 607 
the dataset to plot fraction bound. Data were fitted to the Kd model using MO.Affinity Analysis 608 
software (NanoTemper) and were plotted using Prism 8.0.2 (GraphPad). 609 
 610 
Conjugation of a fluorescent label to the surface-exposed cysteine residue (C111) observed 611 
in the 2A crystal structure (Fig. 1e) provided a convenient way of studying binding to multiple 612 
unlabelled targets by MST, in such a way that the observed affinities would be directly 613 
comparable. For this experiment, EMCV 2A protein was labelled using the Protein Labelling 614 
Kit RED-Maleimide (NanoTemper Technologies) according to the manufacturer’s instructions. 615 
In brief, 2A protein was diluted in a buffer containing 10 mM HEPES pH 7.9, 1.0 M NaCl and 616 
dye was mixed at a 1:3 molar ratio at room temperature for 30 min in the dark. Unreacted dye 617 
was removed on a spin gel filtration column equilibrated with 10 mM HEPES pH 7.9, 1.0 M 618 
NaCl. The labelled 2A protein was diluted to 10 nM in MST buffer. Synthetic EMCV RNA 619 
variants were used in dilutions ranging from 0.0008 to 26 μM for RNA 1 and 0.00003 to 1 μM 620 
for RNA 2-6. For the measurement, each RNA ligand dilution was mixed with one volume of 621 
labelled protein 2A, which led to a final concentration of protein 2A of 5.0 nM. Similar 622 
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experiments were conducted with ribosomes in MST buffer, with ligand concentrations ranging 623 
between 0.00002 to 0.4 μM for 40S and 60S, 0.00003 to 1 μM for 30S, 0.000027 to 0.9 μM 624 
for 50S, 0.0008 to 1.375 μM for empty 70S and 0.000003 to 0.1 μM for 70S IC. The 625 
measurements were performed as described above. 626 
 627 
Preparation of constructs for optical tweezer experiments 628 
DNA encoding the frameshifting sequence of EMCV was inserted into plasmid 629 
pMZ_lambda_OT using PCR and subsequent Gibson assembly. This plasmid contains the 630 
ColE1 origin, ampicillin resistance, ribosome binding site and two 2 kbp handle regions derived 631 
from lambda phage DNA (5′ and 3′ handle). For the generation of the mutant plasmid, PCR 632 
and blunt-end ligation was used to mutate the CCC triplet in the EMCV stem-loop to CUC. 633 
Control constructs (see below) were prepared the same way as mutant constructs. For the 634 
control construct without any single-stranded RNA region, a PCR reaction using the EMCV 635 
wild-type (CCC) construct as template was conducted with 3’ handle forward oligonucleotide 636 
and 5’ handle reverse oligonucleotide as primers (Supplementary Table 5) After the PCR, 637 
the linear products were blunt-end ligated to yield the control constructs. Wild-type and mutant 638 
plasmids were subsequently used to generate construct suitable for optical tweezer 639 
measurements consisting of the EMCV frameshifting sequence flanked by the 2 kbp long 640 
handle regions. Three pairs of primers for PCR were designed allowing the amplification of 641 
the in vitro transcription template and 5′ and 3′ handles. Subsequently, PCR reactions 642 
generated 5′ and 3′ handles and a long template for in vitro transcription. The 3′ handle was 643 
labelled during PCR using a 5′ digoxigenin-labelled reverse primer. The 5′ handle was labelled 644 
with Biotin-16-dUTP at the 3′ end following PCR using T4 DNA polymerase. RNA was 645 
transcribed from templates for in vitro transcription using T7 RNA polymerase. RNA and both 646 
DNA handles (5′ and 3′) were annealed together in a mass ratio 1:1:1 (5 µg each) by incubation 647 
at 95 °C for 10 min, 62 °C for 1 hour, 52 °C for 1 hour and slow cooling to 4 °C in a buffer 648 
containing 80% formamide, 400 mM NaCl, 40 mM HEPES, pH 7.5, and 1 mM EDTA69. 649 
Following annealing, the samples were concentrated by ethanol precipitation, the pellets 650 
resuspended in 40 µL RNase-free water, split into 4 µL aliquots and stored at –20 °C. 651 
 652 
Optical tweezers data collection and analysis 653 
Optical tweezer experiments were performed using a commercial dual-trap instrument 654 
equipped with a microfluidics system (C-trap, Lumicks). Optical tweezers (OT) constructs 655 
described above were mixed with 3 µL of polystyrene beads coated with antibodies against 656 
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digoxigenin (0.1% v/v suspension, Ø 1.76 µm, Lumicks), 8 µL of measurement buffer (20 mM 657 
HEPES, pH 7.6, 300 mM KCl, 5 mM MgCl2, 5 mM DTT and 0.05% Tween) and 1 µL of RNase 658 
inhibitors. The mixture was incubated for 20 min at room temperature in a final volume of 16 659 
µL, and subsequently diluted by addition of 0.5 mL measurement buffer. Separately, 0.8 µL of 660 
streptavidin-coated polystyrene beads (1% v/v suspension, Ø 2 µm, Lumicks) was 661 
supplemented with 1 mL of measurement buffer, the flow cell was washed with the 662 
measurement buffer and suspensions of both streptavidin beads as well as the complex of OT 663 
construct with anti-digoxigenin beads were introduced into the flow cell. Per experiment, an 664 
anti-digoxigenin (AD) bead and a streptavidin (SA) bead were optically trapped and brought 665 
into close proximity to allow the formation of a tether in between. The beads were moved apart 666 
(unfolding) and back together (refolding) at constant speed (0.05 µm/s) to yield the force-667 
distance (FD) curves. The stiffness was maintained at 0.31 and 0.24 pN/nm for trap 1 (AD 668 
bead) and trap 2 (SA bead), respectively. For experiments with 2A protein experiments, 669 
protein was diluted to 300 nM in measurement buffer and added to the buffer channel of the 670 
optical tweezer flow cell. FD data was recorded at a rate of 78000 Hz. To ensure that the 671 
observed effects were indeed a result of interaction with the studied RNA region and not a 672 
non-specific binding to handle regions, we also employed constructs containing either no 673 
single-stranded RNA sequence (No ssRNA control) 674 
[http://dx.doi.org/10.17632/gkpwngy65h.2]. No oxygen scavengers were used during 675 
measurements. However, to prevent oxygen damage, all buffers were degassed and 676 
contained DTT as reducing agent. 677 
 678 
Afterwards, the data were down sampled by a factor of 30 and filtered with a Butterworth filter 679 
(0.05 filtering frequency, filter order 4) using a custom-written python algorithm. FD curves 680 
were fitted using a custom written Python script, which is based on Pylake package provided 681 
by Lumicks (https://lumicks-pylake.readthedocs.io/). Scripts have been deposited to GitHub 682 
[https://github.com/REMI-HIRI/EMCV_2A_project]. The fitting procedure was done as 683 
described70. In brief, first, a fully folded part (until the first detectable unfolding step) was fitted 684 
with a worm-like chain model (WLC)71,72 to determine the persistence length (dsLP) of the 685 
tether while the contour length (dsLC) parameter was held fixed at 1256 nm (± 1%; 4110 686 
bp*0.305 nm/bp and 4 ss*0.59 nm/ss)73. The (partially) unfolded parts of FD curve were then 687 
fitted by a model comprising of WLC (describing the folded double stranded handles) and a 688 
second WLC model (describing the unfolded single stranded parts)71,74. For fitting of the 689 
unfolded regions, parameters extracted from the fully folded part fitting (dsLP, dsLC, dsK) were 690 
used and fixed in the WLC part of the combined model. Persistence length of the single 691 
stranded part (ssLP) was fixed at 1 nm while contour length (ssLC) of the single stranded part 692 
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together with the single stranded stretch modulus (ssK) were optimized. The work performed 693 
on the structure while unfolding or refolding was calculated as difference between area under 694 
curve (AUC) of the fit for the folded region and AUC of the fit for the unfolded region, counted 695 
from the beginning of the FD curve till the unfolding step coordinates75. If the unfolding and 696 
refolding work distributions were overlapping, Crook’s fluctuation theorem was applied to 697 
estimate the equilibrium work, which represents free Gibbs energy75, as intersection between 698 
the unfolding and refolding work distributions. Since Crooks fluctuation theorem directly 699 
averages work values of unfolding and folding, it is not reliable when system is far from 700 
equilibrium or in other cases when folding and unfolding work distributions are very different33. 701 
In our WT+2A samples, the overlap between folding and unfolding work was not sufficient. 702 
Therefore, to more accurately estimate the free energies where large fluctuations exist in work 703 
distributions, we applied the Jarzynski’s equality as described34. We then corrected for the 704 
bias in the Jarzynski estimate76. Theoretical values of the Gibbs free energies for the predicted 705 
RNA structures were obtained using mfold31. The FD curves were plotted using Prism 8.0.2 706 
(GraphPad). The RNAstructure software (version 6.2) was also used for prediction of the 707 
EMCV RNA element secondary structure77.  708 
 709 
Eukaryotic ribosomal subunit purification 710 
40S and 60S subunits were purified from untreated rabbit reticulocyte lysate (Green Hectares) 711 
as previously described78. Briefly, ribosomes were pelleted by centrifugation (4°C, 270,000 × 712 
g, 4.5 h) and resuspended in 20 mM Tris-HCl pH 7.5, 4.0 mM MgCl2, 50 mM KCl, 2.0 mM 713 
DTT. Following treatment with 1.0 mM puromycin and addition of KCl to 0.5 M, 40S and 60S 714 
subunits were separated by centrifugation (4°C, 87,000 × g, 16 h) through a sucrose density 715 
gradient (10  30% sucrose in 20 mM Tris-HCl pH 7.5, 2.0 mM DTT, 4.0 mM MgCl2, 0.5 M 716 
KCl). After analysis by SDS-PAGE, uncontaminated fractions were pooled, and exchanged 717 
into 20 mM Tris-HCl pH 7.5, 100 mM KCl, 2.0 mM MgCl2, 2.0 mM DTT, 250 mM sucrose using 718 
Amicon centrifugal concentrators (4°C,100K MWCO). Ribosome subunits were snap-frozen 719 
in liquid nitrogen and stored at -80°C until required.  720 
 721 
Ribosome binding assays   722 
Assays were conducted in 50 mM Tris-acetate pH 7.5, 150 mM potassium acetate, 5.0 mM 723 
magnesium acetate, 0.25 mM spermidine, 10 mM DTT, 0.1 % v/v Triton X-100. Per 60 µL 724 
binding reaction, ribosome subunits were diluted to a final concentration of 0.4 μM, and 2A 725 
protein was added in excess to a final concentration of 2.4 μM. Twenty microlitres of this 726 
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mixture was retained for SDS-PAGE analysis of the ‘input’. The remaining 40 µL was 727 
incubated at room temperature for 20 min prior to application to a S200-HR size-exclusion 728 
microspin column (Cytiva) that had been pre-equilibrated (4 x 500 µL) in the above buffer by 729 
resuspension and centrifugation (300 × g, 30 s). Immediately after application, the eluate was 730 
collected by centrifugation (300 × g, 60 s).   731 
 732 
Western blot 733 
Samples were analysed by 4–20% gradient SDS-PAGE and transferred to a 0.2 μm 734 
nitrocellulose membrane. All subsequent steps were carried out at room temperature. 735 
Membranes were blocked (5% w/v milk, PBS, 1 h) before incubation (1 h) with primary 736 
antibodies in 5% w/v milk, PBS, 0.1% v/v Tween-20. Membranes were washed three times 737 
with PBS, 0.1% v/v Tween-20 prior to incubation (1 h) with IRDye fluorescent antibodies in 738 
5% w/v milk, PBS, 0.1% v/v Tween-20. After three washes in PBS, 0.1% v/v Tween-20 and a 739 
final rinse in PBS, membranes were imaged using an Odyssey CLx Imaging System (LI-COR). 740 
Figures were prepared using ImageStudio Lite 5.2 (LI-COR). Antibodies used were rabbit 741 
polyclonal anti-2A12 (1/1000); mouse monoclonal anti-RPS6 (1/1000, clone A16009C, 742 
BioLegend); mouse monoclonal anti-RPL4 (1/1000, clone 4A3, Sigma); goat anti-rabbit IRDye 743 
800 CW (1/10,000, LI-COR) and goat anti-mouse IRDye 680LT (1/10,000, LI-COR). Raw, 744 
uncropped blots are available in the Source Data file. 745 
 746 
In vitro transcription  747 
For in vitro frameshifting assays, we cloned a 105 nt DNA fragment (pdluc/EMCV, 748 
Supplementary Table 5) containing the EMCV slippery sequence flanked by 12 nt upstream 749 
and 86 nt downstream into the dual luciferase plasmid pDluc at the XhoI and BglII sites79. This 750 
sequence was inserted between the Renilla and firefly luciferase genes such that firefly 751 
luciferase expression is dependent on −1 PRF. Wild-type or mutated frameshift reporter 752 
plasmids were linearized with FspI and capped run-off transcripts generated using T7 RNA 753 
polymerase as described80. Messenger RNAs were recovered by phenol/chloroform extraction 754 
(1:1 v/v), desalted by centrifugation through a NucAway Spin Column (Ambion) and 755 
concentrated by ethanol precipitation. The mRNA was resuspended in water, checked for 756 
integrity by agarose gel electrophoresis, and quantified by spectrophotometry. 757 
Messenger RNAs for 70S IC preparation (EMCV_IC, Supplementary Table 5) were produced 758 
from a 117 nt long DNA fragment containing the EMCV frameshift site flanked by the bacterial 759 
5′ UTR with Shine-Dalgarno sequence and 18 nt downstream region of the putative structure.  760 
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5′GGGAAUUCAAAAAUUGUUAAGAAUUAAGGAGAUAUACAUAUGGAGGUUUUUAUCACUCAA761 
GGAGCGGCAGUGUCAUCAAUGGCUCAAACCCUACUGCCGAACGACUUGGCCAGATCT 3′ 762 
(slippery sequence in bold, initiation codon underlined) 763 
 764 
This sequence was PCR amplified and in vitro transcribed using T7 RNA polymerase 765 
(produced in-house). Messenger RNAs were purified using the Qiagen RNeasy midiprep kit 766 
according to the manufacturer’s protocols. The mRNAs were eluted in RNAse-free water, 767 
integrity and purity was checked by gel electrophoresis and quantified by spectrophotometry.  768 
 769 
70S initiation complex preparation 770 
Ribosomes, translation factors, and tRNAs were of E. coli origin. Total E. coli  tRNA was from 771 
Roche, and oligonucleotides were from Microsynth. 70S ribosomes from MRE600, EF-Tu, EF-772 
G, IF1, IF2 and IF3 were purified from E. coli 81. fMet-tRNAfMet was prepared and aminoacylated 773 
according to published protocols82,83. Aminoacylated fMet-tRNAfMet was purified by reversed-774 
phase HPLC on a Wide Pore C5 (10 µM particle size 10 mm x 25 cm) column (Sigma Aldrich). 775 
To prepare initiation complexes, 70S ribosomes (1 µM) were incubated with a three-fold 776 
excess of an EMCV model mRNA (EMCV_IC, Supplementary Table 5) encoding for 777 
5′…AUGGAGGUUUUUAUC…3′ (slippery sequence in bold) and a 1.5- fold excess each of 778 
IF1, IF2, IF3, and fMet-tRNAfMet in buffer A (50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM 779 
KCl, 7 mM MgCl2) supplemented with GTP (1 mM) for 30 min at 37°C. 70S initiation complexes 780 
were purified by centrifugation through a 1.1 M sucrose cushion in buffer A. Before grid 781 
preparation, initiation complexes were additionally purified on Sephacryl S-300 gel filtration 782 
microspin columns. 783 
 784 
Frameshifting assays (In vitro translation)  785 
Messenger RNAs were translated in nuclease-treated rabbit reticulocyte lysate (RRL) or 786 
wheat germ (WG) extracts (Promega). Typical reactions were composed of 90% v/v RRL, 20 787 
μM amino acids (lacking methionine) and 0.2 MBq [35S]-methionine and programmed with ∼50 788 
μg/mL template mRNA. Reactions were incubated for 1 h at 30°C. Samples were mixed with 789 
10 volumes of 2× Laemmli's sample buffer, boiled for 3 min and resolved by SDS-PAGE. Dried 790 
gels were exposed to a Storage Phosphor Screen (PerkinElmer) and the screen scanned in a 791 
Typhoon FLA7000 using phosphor autoradiography mode. Bands were quantified using 792 
ImageQuant™TL 8.1.0  software (GE Healthcare).  The calculations of frameshifting efficiency 793 
(%FS) took into account the differential methionine content of the various products and %FS 794 
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was calculated as % −1FS = 100 × (IFS/MetFS) / (IS/MetS + IFS/MetFS). In the formula, the 795 
number of methionines in the stop and frameshift products are denoted by MetS, MetFS 796 
respectively; while the densitometry values for the same products are denoted by IS and IFS 797 
respectively. All frameshift assays were carried out a minimum of three times. 798 
 799 
Ribosomal frameshift assays in E. coli employed a coupled T7/S30 in vitro translation system 800 
(Promega). A ~450 bp fragment containing the EMCV PRF signal (or mutant derivative) was 801 
prepared by PCR from plasmid pDluc/EMCV12 and cloned into the BamHI site of the T7-based, 802 
E. coli expression vector pET3xc84. T7/S30 reaction mixes were prepared according to the 803 
manufacturer's instructions (50 µL volumes), including 10 µCi 35S methionine, supplemented 804 
with plasmid DNA (4 µg) and incubated at 37 ˚C for 90 mins. Reactions were precipitated by 805 
addition of an equal volume of acetone, dissolved in Laemmli's sample buffer and aliquots 806 
analysed by SDS-PAGE. PRF efficiencies were calculated as above. 807 
 808 
Cryo-EM specimen preparation  809 
Initiated 70S ribosomes in 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7 mM MgCl2 810 
were diluted tenfold into 20 mM HEPES pH 7.5, 100 mM potassium acetate, 1.5 mM MgCl2, 811 
2.0 mM DTT. 2A protein was dialysed (3K MWCO, 4°C, 16 h) into the same buffer. 812 
Crosslinking reactions of 50 μL comprising 75 nM ribosomes, 3.0 μM 2A and 2.0 mM 813 
bis(sulfosuccinimidyl)suberate (BS3) were performed on ice (30 min) immediately prior to grid 814 
preparation. Quantifoil R 2/2 400-mesh copper supports were coated with an additional ~ 60 815 
Å layer of amorphous, evaporated carbon by flotation85, and thoroughly dried before use. Grids 816 
were made hydrophilic by glow-discharge in air for 30 s. Three microliters of crosslinking 817 
reaction was applied to grids which were then blotted for 4.5 s and vitrified by plunging into 818 
liquid ethane using a Vitrobot MK IV (FEI) at 4°C, 100% relative humidity. 819 
 820 
Cryo-EM data collection and processing 821 
Micrographs were collected at the BiocEM facility (Department of Biochemistry, University of 822 
Cambridge) on a Titan Krios microscope (FEI) operating at 300 kV and equipped with a Falcon 823 
III detector (Supplementary Table 4). At 75,000 × magnification, the calibrated pixel size was 824 
1.07 Å / pixel. Per 0.6 s acquisition in integration mode, a total exposure of 54.4 e- / Å2 was 825 
fractionated over 23 frames with applied defocus of –1.5, –1.8, –2.1, –2.4, –2.7 and –3.0 μm. 826 
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EPU software was used for automated acquisition with five images per hole. After manual 827 
inspection, 5730 micrographs were used in subsequent image processing. 828 
 829 
Movie frames were aligned and a dose-weighted average calculated with MotionCor 286. The 830 
contrast transfer function (CTF) was estimated using CtfFind 487. All subsequent image-831 
processing steps were carried out in RELION 3.188 (Supplementary Fig. 6) and all reported 832 
estimates of resolution are based on the gold standard Fourier shell correlation (FSC) at 0.143, 833 
and the calculated FSC is derived from comparisons between reconstructions from two 834 
independently refined half-sets. Reference-free autopicking of 820,475 particles was 835 
performed using the Laplacian-of-Gaussian function (200 - 250 Å diameter). Particles were 836 
initially downscaled threefold and extracted in a 150-pixel box. Two rounds of 2D classification 837 
(into 100 and 200 classes, respectively) were used to clean the dataset to 750,029 ‘good’ 838 
particles. An initial reference was generated from a PDB file of a 70S elongation-competent 839 
ribosome (PDB ID 5MDZ [http://doi.org/10.2210/pdb5mdz/pdb]) and low-pass filtered to 80 Å 840 
resolution. The initial 3D refinement (6.5 Å resolution) showed clear evidence for at least one 841 
copy of 2A adjacent to the factor binding site on the 30S subunit. At this stage, two rounds of 842 
focussed classification with signal subtraction were performed (6 classes) to separate particles 843 
based on additional density near i) the factor binding site and ii) the mRNA entry 844 
channel/helicase. The former was successful and 289,741 particles containing three copies of 845 
2A were rescaled to full size and extracted in a 450-pixel box. Following initial 3D refinement, 846 
creation of a 15 Å low-pass filtered mask (five-pixel extension and five-pixel soft edge) and 847 
post-processing, a reconstruction of 2.93 Å was achieved. After per-particle CTF refinement 848 
and polishing, this was increased to 2.50 Å. With the increased angular accuracy provided by 849 
the fully rescaled data, focussed classification with signal subtraction and local angular 850 
searches was performed again to separate particles based on 2A occupancy at the factor 851 
binding site. This final reconstruction (2.66 Å) from 120,749 particles revealed three copies of 852 
2A bound with full occupancy, and clearer details in the vicinity of the 2A binding sites. 853 
Calculation of a local resolution map revealed additional low-resolution density adjacent to the 854 
beak of the 30S head. Subsequent focussed classification with signal subtraction and 855 
refinement confirmed that this was a fourth copy of 2A bound, present in 73,059 particles.  856 
 857 
To build the model, the atomic coordinates for a 70S initiation complex (5MDZ 858 
[http://doi.org/10.2210/pdb5mdz/pdb]) and three copies of chain A from the 2A crystal 859 
structure (above) were docked as rigid bodies into the EM map. Local rebuilding was 860 
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performed iteratively in COOT63 and the models refined using phenix real-space refine64 861 
implementing reference model restraints to preserve geometry.  862 
 863 
Visualisation of structural data 864 
All structural figures depicting crystallographic data (cartoon, stick and surface 865 
representations) were rendered in PyMOL 2.3.4 (Schrödinger LLC). Structural figures of EM 866 
maps with docked components were rendered in ChimeraX 1.189. 867 
 868 
Data Availability  869 
The atomic coordinates and structure factors for the EMCV 2A X-ray crystal structure have 870 
been deposited in the wwPDB database under accession code 7BNY 871 
[http://doi.org/10.2210/pdb7bny/pdb]. The 70S IC:2A cryo-EM map has been deposited in the 872 
EMDB under accession code EMD-12635 [https://www.ebi.ac.uk/emdb/EMD-12257] and the 873 
refined atomic coordinates accompanying this structure have been deposited to the wwPDB 874 
under accession code 7NWT [http://doi.org/10.2210/pdb7nwt/pdb]. Previously published 875 
structures that were used in this study are also available in the wwPDB: 5WE6 876 
[http://doi.org/10.2210/pdb5we6/pdb], 4V7D [http://doi.org/10.2210/pdb4v7d/pdb] and 5MDZ 877 
[http://doi.org/10.2210/pdb5mdz/pdb]. Source data are provided with this paper. All raw data 878 
(e.g. uncropped, unannotated gels, western blots, tables of force measurements, MST traces) 879 
corresponding to individual figure panels are provided in the Source Data File and have also 880 
been deposited in Mendeley Data [http://dx.doi.org/10.17632/gkpwngy65h.2]. 881 
 882 
Code Availability  883 
The force spectroscopy analysis scripts supporting the current study have been uploaded to 884 
GitHub [https://github.com/REMI-HIRI/EMCV_2A_project]. Further information is available 885 
on request from Neva Caliskan (neva.caliskan@helmholtz-hiri.de). 886 
  887 
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 1132 
Figures 1133 
 1134 
Figure 1. 2A adopts a highly basic RNA-binding fold with intrinsic flexibility. a, SDS-1135 
PAGE analysis of EMCV 2A (Coomassie). Representative gel from five independent 1136 
purifications. b, SEC-MALS analysis of 2A. The differential refractive index is shown across 1137 
the elution profile (blue) and weight-averaged molar masses of the indicated peaks are listed. 1138 
c, Topological diagram of “beta-shell” fold: a curved central sheet comprising seven 1139 
antiparallel beta strands, supported by two helices. d, Crystal structure of EMCV 2A in three 1140 
orthogonal views. N- and C- termini are indicated. <Inset> Electrostatic surface potential 1141 
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calculated at pH 7.4, coloured between +3 (blue) and -3 (red) kT/e-. e, Four molecules of 2A 1142 
are present in the asymmetric unit of the crystal, arranged as two pairs of disulfide-linked 1143 
dimers (spheres). f, Superposition of the four NCS-related 2A chains in e reveals regions of 1144 
conformational flexibility. The width of the cartoon is proportional to atomic B-factor. <Insets> 1145 
Close-up view of surface loops exhibiting the greatest variation per molecule. Flexible 1146 
sidechains are shown as sticks, and the Cα backbone deviation is indicated in Å. The positions 1147 
of two sulfate ions from the crystallisation buffer are indicated with spheres. Source data are 1148 
provided as a Source Data file. 1149 
 1150 
  1151 
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 1152 
Figure 2. 2A binds to a minimal 47 nt element in the viral RNA. a-b, Sequences and 1153 
schematic diagrams of the EMCV 1–6 constructs used to assay 2A binding. c, EMSA analyses 1154 
showing that removal of the 5′ extension (blue) disables 2A binding. d, Microscale 1155 
thermophoresis (MST) was used to quantify the interactions observed in c. All measurements 1156 
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were repeated as two independent experiments and error bars represent the standard 1157 
deviation from the mean. RNA concentration ranges between 60 pM – 20 µM (for EMCV 1) 1158 
and 150 pM – 5 µM (for EMCV 2–6). Source data are provided as a Source Data file. 1159 
  1160 
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 1161 
Figure 3. Conformations of EMCV frameshifting RNA and effect of 2A on RNA 1162 
unwinding. a, <Upper> Schematic diagram illustrating the optical tweezer experiments (right). 1163 
RNA is hybridized to ssDNA handles and immobilised on beads. These are used to exert 1164 
pulling force on the RNA with a focused laser beam. <Lower> Primary sequence of the 1165 
construct used in optical tweezer experiments, colour coded as in Fig. 2. The location of the 1166 
cytosine triplet (wild-type, WT) and point mutation (CUC) is indicated. b, Predicted 1167 
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conformations of the RNA construct in a. The number of nucleotides involved in each folded 1168 
structure is indicated. Also see Supplementary Table S6.  c, Representative force-distance 1169 
curves of the unfolding (pink) and refolding (blue) transitions of the wild type (WT) CCC RNA 1170 
element.  d, Representative force-distance curves of the unfolding (pink) and refolding (blue) 1171 
transitions of the wild type (WT) CCC RNA element in the presence of 300 nM 2A protein.  e, 1172 
Global analysis of all the unfolding force trajectories. Number of individual measurements are 1173 
WT=117, WT+2A=104, CUC=85, CUC+2A=109. Data (black line) are presented as mean 1174 
values ± SD error bars. f, Global analysis of all refolding force trajectories. Number of individual 1175 
measurements are WT=111, WT+2A=89, CUC=74, CUC+2A=97. Data (black line) are 1176 
presented as mean values ± SD error bars. Source data are provided as a Source Data file. 1177 
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 1180 
Figure 4. 2A binds directly to eukaryotic and prokaryotic ribosomes. a, MST binding 1181 
curves and apparent KD values using unlabelled 40S subunits at a concentration range of 20 1182 
pM – 0.4 μM. All measurements were repeated as two independent experiments and error 1183 
bars represent the standard deviation from the mean. 2A binds with high affinity to the small 1184 
ribosomal subunit. b, As in a with 60S subunits. Error bars as above. c, Binding curve and 1185 
apparent KD values using unlabelled 30S subunits at a concentration range of 30 pM – 1 μM. 1186 
Error bars as above. 2A shows a strong interaction with the prokaryotic small subunit. d, As 1187 
in c with 50S subunits at a concentration range of 27 pM – 0.9 μM. e, Binding curves and 1188 
reported KD values for 2A-70S IC interactions. Error bars as above. f, Same as e, with 2A and 1189 
vacant 70S. Source data are provided as a Source Data file. 1190 
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 1193 
Figure 5. 2A binds to the 70S ribosome via interactions with the 16S rRNA. a, Cryo-EM 1194 
analysis of a complex formed between initiated E. coli 70S ribosomes and EMCV 2A. Images 1195 
(× 75,000) were recorded on a Titan Krios microscope. Representative micrograph from 1196 
dataset of 5730 images. b, Cryo-EM map at 2.7 Å resolution after focused classification and 1197 
refinement. Three copies of 2A (orange, red, yellow) are bound to the 16S rRNA of the small 1198 
(30S) subunit (blue ribbon). c, Close-up view of the 2A binding site. Ribbon diagrams of 2A 1199 
(coloured as above) and ribosomal RNA (purple) are shown. Protein N- and C- termini are 1200 
labelled. d, Superposition of the three copies of 2A reveals a common RNA-binding surface 1201 
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with conformational flexibility. Residues involved in rRNA binding are labelled and shown as 1202 
sticks. 1203 
 1204 
  1205 
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 1206 
 1207 
Figure 6. The ‘arginine loop’ plays a central role in RNA recognition. a-c, Details of rRNA 1208 
recognition by 2A. For each copy of 2A, selected residues involved in interactions are labelled 1209 
and shown as sticks <Insets> View of the rRNA surface bound by each copy of 2A. The rRNA 1210 
helices are colour-coded and labelled. The 2A contact surface is shown as a coloured mesh 1211 
(orange, red and yellow, respectively). d–f, Close-up view of interactions between the 2A 1212 
‘arginine loop’ residues (R95, R97 and R100) and the rRNA backbone (sticks) for each copy 1213 
of 2A (orange, red, yellow). Polar or electrostatic contacts are indicated by a green dashed 1214 
line.  1215 
 1216 
  1217 
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 1218 
Figure 7. 2A binding may clash with translational GTPases. a, Ribbon diagram of initiated 1219 
70S-mRNA-tRNAfMet-2A complex. Ribosome sites are labelled A, P and E. The initiator 1220 
tRNAfMet (dark green), mRNA (light green), and 2A (orange, red, yellow) are shown in two 1221 
orthogonal views. b, Comparison of 70S-2A complex to 70S pre-translocation complex with 1222 
EF-G (4V7D [http://doi.org/10.2210/pdb4v7d/pdb]). 2A binding would clash (red wedges) with 1223 
EF-G binding. c, Comparison of 70S-2A complex to 70S complex with EF-Tu (5WE6 1224 
[http://doi.org/10.2210/pdb5we6/pdb]). 2A binding would clash (red wedges) with EF-Tu 1225 
binding. 1226 
 1227 
  1228 
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 1229 
Figure 8. Molecular basis for 2A-induced reprogramming of gene expression. The PRF 1230 
stimulatory RNA element is predicted to form either stem-loop or pseudoknot conformations. 1231 
As 2A accumulates during EMCV infection, it selectively binds to and stabilises a pseudoknot-1232 
like conformation of the PRF stimulatory element, thereby enabling PRF, producing trans-1233 
frame product 2B* and downregulating the expression of enzymatic viral proteins later in 1234 
infection. 2A also binds directly to the small ribosomal subunit at the translational GTPase 1235 
factor binding site, progressively inhibiting both initiation and elongation as it accumulates. 1236 
This may contribute to the shutdown of host cell translation during lytic infection.   1237 
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Supplementary Figures 1239 
 1240 
Supplementary Figure 1 – related to Figure 1. Details of previously described 2A 1241 
sequence motifs, deletions and point mutations. a, Structural consequences of the 2AΔ39-1242 
97 mutation described by Svitkin et al 1. Deleted amino acids are highlighted in red. b, 1243 
Truncation fragments 2A1-50, 2A51-100 and 2A101-143 described by Petty et al 2. In each case the 1244 
remaining fragment is highlighted in blue and overlaid against the structure of the full protein 1245 
for context. c, Deletion mutants 2AΔ40-97 and 2AΔ94-100 as described by Groppo et al 3. Deleted 1246 
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amino acids are highlighted in green. d, Location of point-mutations made by Groppo et al in 1247 
the putative nuclear localisation sequence and putative C-terminal YxxxxLΦ eIF4E binding 1248 
motif. Mutated amino acids are shown as coloured sticks. e, Comparison of 4E-BP1 YxxxxLΦ 1249 
binding motif and the putative YxxxxLΦ motif in 2A. The crystal structure of the complex 1250 
between eIF4E (green) and 4E-BP1 (blue) is shown (Siddiqui et al., 3U7X) with 2A (wheat) 1251 
docked via least-squares superposition of the YxxxxLΦ motif. <Insets> Contrast between the 1252 
2A YxxxxLΦ motif, in an extended β-strand conformation (wheat), and the 4E-BP1 YxxxxLΦ 1253 
motif, in a compact α-helical conformation, with Y129 partially buried (~ 20% solvent-1254 
accessible surface area; SASA). 2A binding to eIF4E is thus not compatible with the known 1255 
4E-BP1 interface without substantial conformational rearrangement.  1256 
 1257 
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 1258 
Supplementary Figure 2 – related to Figure 2. The 2A-RNA interaction does not require 1259 
disulfide bond formation and is an exergonic process with nanomolar affinity and 1:1 1260 
stoichiometry. a, Side-by-side comparisons of 2Awt, 2A9-136; C111S and SII-2Awt. Equivalent 1261 
RNA binding is observed in all cases by EMSA analyses conducted with 50 nM Cy5-labelled 1262 
EMCV 6 RNA and 2A concentrations between zero and 9.6 μM. Following non-denaturing 1263 
electrophoresis, fluorescence was imaged using a Typhoon scanner. Showing representative 1264 
gels from two independent experiments. b, Baseline-corrected differential power (DP) versus 1265 
time for ITC titration of EMCV 6 RNA into 2A protein. c, Normalized binding curve showing 1266 
integrated changes in enthalpy (ΔH) against molar ratio for titration in b, showing a ~1:1 molar 1267 
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ratio and nanomolar affinity <Inset> Histogram showing relative contributions of ΔH and TΔS 1268 
terms to the overall exergonic interaction. d, MST binding curves and reported KD values of 1269 
fluorescently labelled 2A protein (5 nM) and short unlabelled RNAs (as in Fig. 2a, b) at 1270 
concentrations between 800 pM – 26 μM for EMCV 1 and 120 pM – 4 μM for EMCV 2–6. All 1271 
measurements were repeated as two independent experiments and error bars represent the 1272 
standard deviation from the mean. e, Experiment showing the effects of titrating excess short 1273 
RNAs (EMCV 1–6) as competitors into an in vitro frameshift reporter assay. The 1274 
concentrations of the reporter mRNA and 2A were kept constant in the RRL and short RNAs 1275 
were added in 10- and 100- fold molar excess relative to the reporter mRNA, as indicated. 1276 
Translation products were visualised by using 35S-Met autoradiography, and % frameshifting 1277 
was calculated following densitometry and correction for the number of methionines present 1278 
in 0 frame and –1 frame products. Showing representative gel from two independent 1279 
experiments. 1280 
  1281 
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 1282 
Supplementary Figure 3 – related to Figure 2 and 3. Mutational analysis of the RNA 1283 
stimulatory element suggests the existence of a pseudoknot-like conformation. a, 1284 
Schematic diagram showing numbered sequence of the EMCV 6 minimal PRF stimulatory 1285 
element. b, Frameshifting assays showing evidence for a base-pairing interaction between G7 1286 
and C37. Individual G7C and C37C mutations reduce frameshifting to near-background levels. 1287 
However, the double mutation (which would permit a compensatory C-G base-pair to form) 1288 
restores frameshifting to wild-type levels. Representative autoradiogram from two 1289 
independent experiments c, EMSA analyses showing that individual G7C and C37G 1290 
mutations in the EMCV 6 RNA prevent 2A binding, but the double G7C+C37G mutation 1291 
restores binding. Experiments were conducted with 50 nM Cy5-labelled EMCV 3 RNA variants 1292 
and 2A concentrations between zero and 32 μM. Following non-denaturing electrophoresis, 1293 
fluorescence was imaged using a Typhoon scanner. Showing representative gels from two 1294 
independent experiments. d, Hypothetical equilibrium between several predicted stem-loops 1295 
and alternate pseudoknot conformations, colour-coded as in a. The pseudoknot-like 1296 
conformation involves base pairs between G7 and G8 in the 5′ extension and C36 and C37 in 1297 
the loop (shown as sticks). These interactions are not maintained in any predicted stem-loop 1298 
conformation. Predicted stem loops may involve 35 nt (core) or 49 nt (extended) structured 1299 
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RNA. The predicted pseudoknot involves 40 nt structured RNA. Also see Supplementary 1300 
Table 6.  1301 
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 1302 
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Supplementary Figure 4 (previous page) – related to Figure 3. Details of contour length, 1303 
force and work distributions observed in optical tweezer experiments. a, Representative 1304 
force-distance curves of the unfolding (pink) and refolding (blue) transitions of the mutant CUC 1305 
RNA element (n=85).  b, Representative force-distance curves of the unfolding (pink) and 1306 
refolding (blue) transitions of the mutant CUC RNA element in the presence of 300 nM 2A 1307 
protein (n=109). c and d, distribution of the contour length changes in the absence (black) and 1308 
presence (grey) of 2A for WT and CUC RNAs, respectively. Dots represent experimental data 1309 
points while the line corresponds to the Gaussian fit. e and f, distribution of the unfolding forces 1310 
in the absence (black) and presence (grey) of 2A for WT and CUC RNAs, respectively. g and 1311 
h, distribution of the refolding forces in the absence (black) and presence (grey) of 2A for WT 1312 
and CUC RNAs, respectively. i and j, distribution of unfolding (pink) and refolding (blue) work 1313 
in the absence (solid) and presence (dashed) of 2A for WT and CUC, respectively.   1314 
 1315 
 1316 
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 1317 
Supplementary Figure 5 – related to Figures 5 and 6. Mutational analysis of 2A RNA 1318 
binding residues observed in the 70SIC-2A structure. Mutation of the ‘arginine loop’ 1319 
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disrupts binding to both stimulatory element RNA and mammalian ribosome subunits, 1320 
and inhibits PRF. a, Frameshifting assay showing the reconstitution of 2A-dependent PRF in 1321 
a prokaryotic in vitro translation system. Translation products were visualised by 35S-Met 1322 
autoradiography and % frameshifting was calculated following densitometry and correction for 1323 
the number of methionines present in 0 frame and –1 frame products. Representative 1324 
autoradiograms from two independent experiments. b, PRF efficiency in the prokaryotic 1325 
system is proportional to 2A concentration. At high levels, 2A displays inhibitory effects on 1326 
total translation. Data analysed as above. c, Mutagenesis of residues at the 2A RNA binding 1327 
surface observed in the 70SIC-2A structure. The locations of mutations R95A/R97A, 1328 
R46A/K48A/K50A and K73A are highlighted in red and shown as sticks. d, EMSA analyses 1329 
showing effects of the above mutations on stimulatory element RNA binding, compared to a 1330 
wild-type control. Panels ordered left-right, as in a. Experiments were conducted with 50 nM 1331 
Cy5-labelled EMCV 6 RNA and 2A concentrations between zero and 10 μM. Following non-1332 
denaturing electrophoresis, fluorescence was imaged using a Typhoon scanner. 1333 
Representative gels from two independent experiments. e, Gel-filtration experiments showing 1334 
effects of the above mutations on eukaryotic ribosome binding, compared to a wild-type 1335 
control. Panels ordered left-right, as in a. Excess 2A (2.5 µM) was incubated with 40S, 60S 1336 
and 80S ribosomes (0.4 µM) prior to gel filtration chromatography using S200HR spin 1337 
columns. In these experiments, 2A will only elute if bound to ribosomes. The input <upper> 1338 
was analysed by 4-20% gradient SDS page and visualised by staining with Imperial protein 1339 
stain. The eluate <lower> was analysed by western blot to detect 2A, RPS6 (small ribosomal 1340 
subunit) and RPL4 (large ribosomal subunit). Experiments were performed once, and all 1341 
mutant samples were processed at the same time as wild-type.  f, Frameshift reporter assays 1342 
showing the effects of the above mutations on in vitro translation in RRL. Translation products 1343 
were visualised by 35S-Met autoradiography and % frameshifting was calculated following 1344 
densitometry and correction for the number of methionines present in 0 frame and –1 frame 1345 
products. Representative autoradiograms from two independent experiments. g, Plot of % 1346 
Free RNA vs. 2A concentration, based on densitometric quantification of EMSAs in b. h, Plot 1347 
of % Frameshifting vs. 2A concentration, based on quantification reported in d.  1348 
 1349 
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 1350 
Supplementary Figure 6 – related to Figures 5, 6 and 7. Details of cryo-EM image 1351 
processing and map validation. a, Schematic summary of steps in cryo-EM data processing. 1352 
b, Three orthogonal views showing the angular distribution of particles contributing to the final 1353 
  
 
55 
 
3D reconstruction. This is shown for the highest-resolution Refine3D result i.e. immediately 1354 
after particle polishing. c, Local-resolution map for the final reconstruction of 70S-2A3. The 1355 
surface is coloured by local resolution from red (highest; 2.4 Å) to blue (lowest; 8.3 Å). d, Gold-1356 
standard Fourier shell correlation (FSC) curve for the 70S-2A3 map. Masked (blue), unmasked 1357 
(green) and phase-randomised masked (red) plots are shown.  e, Local-resolution map for the 1358 
final reconstruction of 70S-2A4, details as in c. Local resolution estimate for 2A4 is ~ 5 – 7 Å.  1359 
f, Gold-standard Fourier shell correlation (FSC) curve for the 70S-2A4 map. Details as in d.  1360 
  1361 
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 1362 
Supplementary Figure 7 – related to Figure 5 and 6. Analysis of 2A binding sites 1363 
observed on E. coli 16S rRNA. The 2A1 site is the most structurally conserved. a, 1364 
Diagram showing the binding sites of each 2A molecule (coloured sticks) on the 16S rRNA 1365 
(grey cartoon). Binding sites were defined as rRNA residues within 8.0 Å distance of each 2A 1366 
molecule, as determined by a PDBePISA analysis of molecular contacts. b, As above, 1367 
showing each of the 2A binding sites separately (sticks), superimposed on local 16S rRNA 1368 
(grey cartoon). c, Backbone superposition of the three sites fails to reveal a common binding 1369 
motif. d, Superposition of binding sites (sticks) based on first aligning the three 2A molecules 1370 
(grey ribbon diagrams). Two orthogonal views are shown. <Inset> cartoon representation of 1371 
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RNA backbone shown in the top-down view. e, As in d, but trimmed to show spatial 1372 
conservation (i.e. only residues within 3.0 Å of those in other binding sites. f, Structural 1373 
superposition of 2A binding sites observed on E. coli 16S rRNA (30S, turquoise) with 1374 
equivalent sites on O. cuniculus 18S rRNA (40S, black) The 30S 2A binding patch and 1375 
equivalent 40S rRNA (black) are highlighted. <Inset> Close-up view of 2A binding sites after 1376 
backbone superposition. g, Local alignment of each individual 2A binding site to nearest 1377 
equivalent in 40S rRNA (black). Per site, deviation from the starting position in the 30S rRNA 1378 
(green) was permitted. The binding site for 2A1 is the most structurally conserved between 1379 
30S and 40S. 1380 
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 1381 
Supplementary Figure 8 – related to Figure 5, 6 and 7. Structural details of the 70S 1382 
decoding centre, 2A1 interaction with S12 and 2A4 binding site. a, Comparison between 1383 
conformations of 2A protein in RNA bound states (orange, red, yellow) and the two unliganded 1384 
states observed by NCS in the crystal structure. The 2Aapo1 conformation observed in chain 1385 
A is most similar to the RNA-bound state. Structural alignments were performed by least-1386 
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squares superposition of the Cα backbone. b, Details of a base-specific interaction between 1387 
U485 (helix 17 of 16S) and a pocket on the surface of 2A2 (red). c, Cryo-EM density at the P-1388 
site. Codon-anticodon pairing between the mRNA (lime) and the initiator tRNAfMet (dark green). 1389 
The tRNA is in an undistorted P/P conformation as expected. d, Cryo-EM density at the A-1390 
site, coloured as in b. Additional 30S residues with roles in decoding are shown as sticks 1391 
(purple). e, Details of a hydrophobic 2A1 interaction with ribosomal protein S12. The contact 1392 
surface is on the factor-binding face of S12, away from the decoding centre. The binding site 1393 
of antibiotic dityromycin on S12 (from 4WQU4 [http://doi.org/10.2210/pdb4wqu/pdb]) is shown 1394 
with blue sticks. f, Ribbon diagram of initiated 70S-mRNA-tRNAfMet-2A complex showing the 1395 
location of the fourth copy of 2A (pink) present in a smaller population of particles. Ribosome 1396 
sites are labelled A and P. The initiator tRNAfMet (dark green), mRNA (lime), 2A1 (orange), 1397 
2A2 (red) and 2A3 (yellow) are also shown. <Inset> Section of the 70S-2A4 local resolution 1398 
map showing electron density at the 2A4 binding site. 2A4 binds to the 3′ major ‘beak’ domain 1399 
of the 16S rRNA present in the 30S ‘head’, via electrostatic interactions with the ribose 1400 
phosphate backbone of helices 33 and 34. g, Details of 2A4 interaction with 16S rRNA (purple) 1401 
in two orthogonal views.  1402 
 1403 
 1404 
Additional Data [http://dx.doi.org/10.17632/gkpwngy65h.2] – related to Figures 2 and 4. 1405 
Capillary scans and thermophoretic time-traces of microscale thermophoresis (MST) 1406 
measurements of binding between 2A and RNA. a, EMCV RNA 1, b, EMCV RNA 2, c, 1407 
EMCV RNA 3, d, EMCV RNA 4, e, EMCV RNA 5, f, EMCV RNA 5, g, EMCV RNA 6, h, 30S, 1408 
i, 50S, j, 40S, k, 60S, l, 70S and m, 70S IC. The protein was fluorescently labelled, while 1409 
unlabelled ligands were added at different concentrations. The grey boxes in the capillary 1410 
scans mark 20% above and below the average peak fluorescence, the acceptable limit of 1411 
deviations across the fluorescence scans. Blue and red boxes in the time-course traces 1412 
represent the temperature jump and MST-on time (10s), respectively. In all cases, there is no 1413 
adsorption of the labelled protein to the capillaries. See Fig. 2 and Fig. 4 for the resulting 1414 
binding curves. 1415 
 1416 
  1417 
  1418 
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Supplementary Tables 1419 
 1420 
Supplementary Table 1 – Crystallographic data collection and refinement. Related to 1421 
Figure 1. 1422 
 1423 
 Native 
(PDB 7BNY) 
 SeMet 
derivative 
 
Data collection     
Space group P6222    
Cell dimensions     
    a, b, c (Å) 91.5, 91.5, 
316.5 
   
     α, β, γ  (°) 90.0, 90.0, 
120.0 
   
     
  Peak Inflection Remote 
(High E) 
Wavelength (Å) 0.97958 0.97965 0.97974 0.97635 
Resolution (Å) 43.91–2.62  
(2.67–2.62) 
76.53–2.91 
(2.96–2.91) 
79.36–3.08 
(3.13–3.08) 
79.0–2.98 
(3.03–2.98) 
Rpim 0.053 (0.640) 0.062 (0.521) 0.067 (0.548) 0.048 (0.473) 
I / σI 11.5 (1.0) 9.9 (1.2) 9.3 (1.1) 12.9 (1.2) 
Completeness (%) 100.0 (99.8) 99.7 (99.2) 99.9 (99.6) 99.6 (99.0) 
   Anomalous - 99.2 (98.8) 99.3 (99.2) 99.1 (98.7) 
Redundancy 18.9 (19.4) 18.6 (17.2) 18.6 (19.8) 37.4 (38.5) 
   Anomalous - 10.4 (9.3) 10.5 (10.7) 21.0 (20.9) 
CC1/2 0.998 (0.728) 0.997 (0.804) 0.997 (0.822) 0.999 (0.834) 
CCanom - 0.400 (0.024) 0.167 (0.000) 0.314 (0.002) 
     
Refinement     
Resolution (Å) 43.91–2.62 
(2.71–2.62) 
   
No. reflections 24589 (2375)    
Rwork / Rfree 0.2254 / 0.2511    
No. atoms     
    Protein 4404    
    Ligand/ion 45    
    Water 147    
B-factors     
    Protein 75.0    
    Ligand/ion 110.0    
    Water 64.9    
R.m.s deviations     
    Bond lengths (Å) 0.003    
    Bond angles (°) 0.741    
*Data were recorded from a single native crystal and a single crystal of selenomethionine-derivatised 1424 
protein (SeMet). *Values in parentheses are for the highest-resolution shell.  1425 
  1426 
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Supplementary Table 2 - Summary of dissociation constants (KD) measured by 1427 
microscale thermophoresis with various 2A interaction partners. Related to Figures 2, 4 and 1428 
Supplementary Figure 2.  1429 
 1430 
 KD (LABELLED 2A) KD  (LABELLED RNA)  
EMCV 1 360 ± 34 nM 490 ± 45 nM 
EMCV 2 No binding No binding 
EMCV 3 40 ± 2 nM 31 ± 4 nM 
EMCV 4 No binding No binding 
EMCV 5 > 4 µM (does not reach saturation) > 4 µM (does not reach saturation)  
EMCV 6 70 ± 14 nM 50 ± 12 nM 
40S 10 ± 2 nM (apparent) N/A 
60S > 1000 nM (apparent; does not reach 
saturation) 
N/A 
30S 4 ± 1 nM (apparent) N/A 
50S > 500 nM (apparent) N/A 
70S 49 ± 13 nM (apparent) N/A 
70S IC > 60 nM (apparent; does not reach 
saturation) 
N/A 
 1431 
 1432 
 1433 
Supplementary Table 3 – Summary of experimental OT results and predicted mfold 1434 
data for EMCV WT and CUC RNAs in the absence or presence of 2A. Results were 1435 
determined by gaussian fitting of the distribution histograms of obtained data (number of 1436 
tethers used in the experiments was >15, and number of force trajectories range between 1437 
85-120). Related to Figure 3 and Supplementary Figure 4. Uncertainties represent 1438 
standard deviations. 1439 
 WT WT + 2A CUC CUC + 2A 
Contour length 
change, nm 26.3±5.4 20.1±3.4 27.2±4.3 23.0±5.5 
Unfolding force, 
pN 
 
9.3±2.3 9.2±2.9 27.0±4.2 8.6±4.2 10.3±2.4 
Refolding force, 
pN 6.5±3.0 9.6±2.7 8.2±2.7 6.6±5.1 
Gibbs free 
energy (mfold), 
kcal/mol 
-14.0±0.7 (SL), 
-16.2±0.8  
(extended SL) 
 
-14.0±0.7 (SL), 
-16.2±0.8  
(extended SL) 
 
Gibbs free 
energy 
(experiment), 
kcal/mol 
-13.6±4.6* 
-11.6±0.9** 
- 
-26.5±8.7** 
-14.5±4.7* 
-11.0±1.6** 
-15.5±5.0* 
-12.9±1.2** 
*Calculated by applying Crook’s fluctuation theorem to unfolding/refolding work distributions. 1440 
Uncertainty represents standard deviation. 1441 
**Calculated by applying Jarzynski’s equality. Uncertainty represents root of mean square 1442 
error. 1443 
Of note, free energy values of the CUC and WT (without 2A) RNAs were in good agreement 1444 
regardless of the calculation method employed. 1445 
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Supplementary Table 4 – Cryo-EM data collection, processing, refinement and 1446 
validation. Related to Figures 5–7, Supplementary Figure 6 and 7. 1447 
 1448 
 70SIC-2A complex 
(EMDB-12635) 
(PDB 7NWT) 
Data collection and processing  
Magnification    75,000x 
Voltage (kV) 300 
Electron exposure (e–/Å2) 54.4 
Defocus range (μm) –1.2, –1.5, –1.8, –2.1, –2.4, –2.7, –3.0 
Pixel size (Å) 1.07 
Symmetry imposed C1 
Initial particle images (no.) 820,475 
Final particle images (no.) 120,749 
Map resolution (Å) 
    FSC threshold 
2.66 
0.143 
Map resolution range (Å) 2.66 – 8.3 
  
Refinement  
Initial model used (PDB code) 5MDZ 
Model resolution (Å) 
    FSC threshold 
2.66 
0.143 
Map sharpening B factor (Å2) -88.5 
Model composition 
    Non-hydrogen atoms 
    Protein residues 
    Nucleic acid residues 
    Ligands 
 
149932 
6355 
4641 
439 
B factors (Å2) 
    Protein 
    Nucleic Acid 
    Ligand 
 
53.87 
49.01   
34.31  
R.m.s. deviations 
    Bond lengths (Å) 
    Bond angles (°) 
 
0.011 
0.830 
  
Validation 
    MolProbity score 
    Clashscore 
    Poor rotamers (%)    
 
1.73 
4.84 
2.95 
 Ramachandran plot 
    Favored (%) 
    Allowed (%) 
    Disallowed (%) 
 
97.41 
2.58 
0.02 
 1449 
  1450 
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Supplementary Table 5 – Oligonucleotide sequences. Related to Methods.  1451 
RNAs  SOURCE / REF 
EMCV 1 used in EMSA and MST assays: 
5’ – 
ACUCAAGGAGCGGCAGUGUCAUCAAUGGCUCAAACCCUACUGCCGAAC
GACUUG – 3’  
 
Integrated DNA 
Technologies 
(IDT) 
EMCV 2 used in EMSA and MST assays: 
5’ – 
AGCGGCAGUGUCAUCAAUGGCUCAAACCCUACUGCCGAACGACUUG – 
3’  
 
Integrated DNA 
Technologies 
(IDT) 
EMCV 3 used in EMSA and MST assays: 
5’ – 
GGGUUUUUCAGACUCAAGGAGCGGCAGUGUCAUCAAUGGCUCAAACCC
UACUGCCGAA – 3’  
 
Integrated DNA 
Technologies 
(IDT) 
EMCV 3a used in EMSA  
5’ – 
GGGUUUUUCAGACUCAAGGAGCGGCAGUGUCAUCAAUGGCUCAAACC
GUACUGCCGAA – 3’  
 
Integrated DNA 
Technologies 
(IDT) 
EMCV 3b used in EMSA 
5’ – 
GGGUUUUUCAGACUCAACGAGCGGCAGUGUCAUCAAUGGCUCAAACCC
UACUGCCGAA – 3’  
 
Integrated DNA 
Technologies 
(IDT) 
EMCV 3c used in EMSA 
5’ –
GGGUUUUUCAGACUCAACGAGCGGCAGUGUCAUCAAUGGCUCAAACCG
UACUGCCGAA – 3’  
 
Integrated DNA 
Technologies 
(IDT) 
EMCV 4 used in EMSA and MST assays: 
5’ – AGCGGCAGUGUCAUCAAUGGCUCAAACCCUACUGCCGAA – 3’  
 
 
Integrated DNA 
Technologies 
(IDT) 
EMCV 5 used in EMSA and MST assays: 
5’ – 
GGGUUUUUCAGACUCAAGGAGCGGCAGUCAAACCCUACUGCCGAACGA
CUUG – 3’  
 
Integrated DNA 
Technologies 
(IDT) 
EMCV 6 used in EMSA and MST assays: 
5’ – 
ACUCAAGGAGCGGCAGUGUCAUCAAUGGCUCAAACCCUACUGCCGAA – 
3’  
 
Integrated DNA 
Technologies 
(IDT) 
70S_IC transcribed mRNA (used in 70S IC preparation): 
5’ – 
GGGAAUUCAAAAAUUGUUAAGAAUUAAGGAGAUAUACAUAUGGAGGUU
UUUAUCACUCAAGGAGCGGCAGUGUCAUCAAUGGCUCAAACCCUACUG
CCGAACGACUUGGCCAGATCT – 3’  
 
This work 
EMCV CCC OT ssRNA region of the OT construct (used in OT experiments): 
5’– 
GAGGUUUUUAUCCUCAAGGAGCGGCAGUGUCAUCAAUGGCUCAAACCC
UACUGCCGAACGACUUGGACUUAAUUUAAAAAAAAAAAAAAAAAAA 
– 3’  
 
This work 
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EMCV CUC OT ssRNA region of the OT construct (used in OT experiments): 
5’ – 
GAGGUUUUUAUCCUCAAGGAGCGGCAGUGUCAUCAAUGGCUCAAACUC
UACUGCCGAACGACUUGGACUUAAUUUAAAAAAAAAAAAAAAAAAA – 3’  
 
This work 
DNA Oligonucleotides SOURCE / REF 
E2A_F1 primer (used for cloning EMCV 2A): 
5’ – AATTCATATGAGCCCCAACCCTTTGGATGTC – 3’  
 
Sigma-Aldrich 
VC00021 
E2A_R1 primer (used for cloning EMCV 2A): 
5’ – AATTGGATCCCCCGGGATTGGTCTCGACATC – 3’  
 
Sigma-Aldrich 
VC00021 
E2A_F2 primer (used to clone EMCV 2A 9-136 construct): 
5’ – AATTCATATGAAAACTTACCCAACTCTGCACAT – 3’  
 
Sigma-Aldrich 
VC00021 
E2A_R2 primer (used to clone EMCV 2A 9-136 construct]): 
5’ – AATTGGATCCTCATTAGTGGATCAAAAGATCTGAAAAGTATCCT – 3’  
 
Sigma-Aldrich 
VC00021 
E2A_mut_F1 mutagenesis primer (used to introduce 2A mutant C111S): 
5’ – AAAGAGTGGAGGACTTCTGAAGAGAATGTTTTT – 3’  
 
Sigma-Aldrich 
VC00021 
E2A_mut_R1 mutagenesis primer (used to create 2A C111S): 
5’ – AAAAACATTCTCTTCAGAAGTCCTCCACTCTTT – 3’  
 
Sigma-Aldrich 
VC00021 
E2A_mut_F2 mutagenesis primer (used to create 2A R46A/K48A/K50A): 
5’ – 
AACACATGCAGAAGTGGTGCTTGCGTCAGCGACAGCACAAATCAGCTTC
CTGAGCAA – 3’  
 
Sigma-Aldrich 
VC00021 
E2A_mut_R2 mutagenesis primer (used to create 2A R46A/K48A/K50A): 
5’ – 
TTGCTCAGGAAGCTGATTTGTGCTGTCGCTGACGCAAGCACCACTTCTG
CATGTGTT – 3’  
 
Sigma-Aldrich 
VC00021 
E2A_mut_F3 mutagenesis primer (used to create 2A K74A): 
5’ – CACCGTTAAACCCCTGGGCGAGCACATATCAGGCAGT – 3’  
 
Sigma-Aldrich 
VC00021 
E2A_mut_R3 mutagenesis primer (used to create 2A K74A): 
5’ – ACTGCCTGATATGTGCTCGCCCAGGGGTTTAACGGTG – 3’  
 
Sigma-Aldrich 
VC00021 
SII_F cloning oligonucleotide (used to insert StrepII-tag into 2A_pGEX6P1): 
5’ – 
GATCCTGGTCACATCCGCAGTTTGAAAAAGGTAGCGCAGGTAGTGCAGC
AGGTAGCGGTGCAGGTTGGAGCCACCCTCAGTTTGAGAAAG – 3’  
 
Sigma-Aldrich 
VC00021 
SII_R cloning oligonucleotide (used to insert StrepII-tag into 2A_pGEX6P1): 
5’ – 
GATCCTTTCTCAAACTGAGGGTGGCTCCAACCTGCACCGCTACCTGCTG
CACTACCTGCGCTACCTTTTTCAAACTGCGGATGTGACCAG – 3’ 
 
Sigma-Aldrich 
VC00021 
 
pdluc/EMCV reporter construct sequence (used in frameshift assays): 
5’-
AAGACAACGGCCGGTTTTTCAGACTCAAGGAGCGGCAGTGTCATCAATG
GCTCAAACCCTACTGCCGAACGACTTGGCCAGCAAAcgTATGGGATCAGC
CTTTAC– 3’ 
 
Napthine et al., 
2017 
Transcription template forward primer (used in 70S IC preparation): 
5’ – GTTGTGTGGAATTGTGAGCGGAT– 3’  
 
Transcription template reverse primer (used in 70S IC preparation): 
Microsynth 
 
 
Microsynth 
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5’ – GGCCAAGTCGTTCGG – 3’  
 
5' handle T7 forward PCR primer (used to generate OT 5’ handle): 
5’ – CTTAATACGACTCACTATAGGTCCTTTCTGTGGACGCC – 3’  
 
Microsynth 
5’ handle reverse PCR primer (used to generate OT 5’ handle and clone 
short ssRNA control construct): 
5’ – CATAAATACCTCTTTACTAATATATATACCTTCGTAAGCTAGCGT – 3’  
 
Microsynth 
5’ handle short single stranded control PCR primer (used to generate OT 
5’ handle for short ssRNA control and clone no ssRNA control construct): 
5’- 
GTAGCTGTCGAGCTCCTGCGAAGAGCGCAACCATGTTATCCAGTGAG– 3’  
 
Microsynth 
3’ handle forward PCR primer (used to generate OT 3’ handle and to clone 
both of the control constructs): 
5’ – ATCCTGCAACCTGCTCTTCGCCAG – 3’  
 
Microsynth 
3’ handle reverse 5’labeled with digoxigenin PCR primer (used to generate 
OT 3’ handle): 
5’ –[Dig]-GTCAAAGTGCGCCCCGTTATCC – 3’  
 
Microsynth 
CUC mutant forward cloning oligonucleotide (used to insert the point 
mutation of CCC motif): 
5’ – CTCTACTGCCGAACGACTTGGCC – 3’  
 
Microsynth 
CUC mutant reverse cloning oligonucleotide (used to insert the point 
mutation of CCC motif): 
5’ – TTTGAGCCATTGATGACACTGCCG – 3’  
 
Microsynth 
The name of each oligonucleotide is highlighted in bold italics, as referred to in Methods.  1452 
  1453 
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Supplementary Table 6 – Predicted secondary structures of the EMCV PRF RNA element. 1454 
Related to Fig. 3 and Supplementary Fig. 4.  1455 
 1456 
 
Structure 
Expected 
contour length, 
nm / nt 
 
Predicted secondary structure 
 
Primary 
sequence 
 
55.5 / 94 
GAGGUUUUUAUCCUCAAGGAGCGGCAGUGUCAUCAAUGG
CUCAAACCCUACUGCCGAACGACUUGGACUUAAUUUAAAA
AAAAAAAAAAAAAAA 
  
 
 
 
 
Stem-loop 
 
 
 
 
20.7 / 35 
 
 
 
 
 
 
 
 
 
Extended 
stem-loop 
 
 
 
 
 
 
28.9 / 49 
 
 
 
 
 
 
 
Pseudoknot 
 
 
 
 
23.5 / 40 
 
 
 
  1457 
 1458 
  1459 
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Source Data for Supplementary Figures (uncropped images, 1460 
autoradiograms, gel scans, phosphorimager scans) 1461 
 1462 
Supplementary Figure 2 – panel A (fluorescent gels) 1463 
 1464 
 1465 
 1466 
Supplementary Figure 2 – panel E (phosphorimager scan) 1467 
 1468 
 1469 
 1470 
  1471 
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Supplementary Figure 3 – panel B (phosphorimager scan) 1472 
 1473 
 1474 
Supplementary Figure 3 – panel C (fluorescent gels) 1475 
1476 
 1477 
 1478 
  1479 
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Supplementary Figure 5 – panel A (phosphorimager scan) 1480 
 1481 
Supplementary Figure 5 – panel B (phosphorimager scan) 1482 
 1483 
Supplementary Figure 5 – panel D (fluorescent gels) 1484 
 1485 
 1486 
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Supplementary Figure 5 – panel E (Imperial-stained input gels. The molecular weight 1487 
ladders are the Precision Plus Protein Dual Color Standards [BioRad, 1610374]) 1488 
 1489 
 1490 
 1491 
  1492 
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Supplementary Figure 5 – panel E (LI-COR fluorescent scans of eluate blots, green channel 1493 
– anti-S6 and anti-L4 ribosomal proteins; red channel anti-2A. The molecular weight ladders 1494 
are the Precision Plus Protein Dual Color Standards [BioRad, 1610374]) 1495 
 1496 
 1497 
  1498 
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Supplementary Figure 5 – panel F (autoradiograms) 1499 
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